Original Article
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
N Engl J Med 2005; 353:999-1007September 8, 2005
- Abstract
Background
Endothelial progenitor cells derived from bone marrow are believed to support the integrity of the vascular endothelium. The number and function of endothelial progenitor cells correlate inversely with cardiovascular risk factors, but the prognostic value associated with circulating endothelial progenitor cells has not been defined.
Methods
The number of endothelial progenitor cells positive for CD34 and kinase insert domain receptor (KDR) was determined with the use of flow cytometry in 519 patients with coronary artery disease as confirmed on angiography. After 12 months, we evaluated the association between baseline levels of endothelial progenitor cells and death from cardiovascular causes, the occurrence of a first major cardiovascular event (myocardial infarction, hospitalization, revascularization, or death from cardiovascular causes), revascularization, hospitalization, and death from all causes.
Results
A total of 43 participants died, 23 from cardiovascular causes. A first major cardiovascular event occurred in 214 patients. The cumulative event-free survival rate increased stepwise across three increasing baseline levels of endothelial progenitor cells in an analysis of death from cardiovascular causes, a first major cardiovascular event, revascularization, and hospitalization. After adjustment for age, sex, vascular risk factors, and other relevant variables, increased levels of endothelial progenitor cells were associated with a reduced risk of death from cardiovascular causes (hazard ratio, 0.31; 95 percent confidence interval, 0.16 to 0.63; P=0.001), a first major cardiovascular event (hazard ratio, 0.74; 95 percent confidence interval, 0.62 to 0.89; P=0.002), revascularization (hazard ratio, 0.77; 95 percent confidence interval, 0.62 to 0.95; P=0.02), and hospitalization (hazard ratio, 0.76; 95 percent confidence interval, 0.63 to 0.94; P=0.01). Endothelial progenitor-cell levels were not predictive of myocardial infarction or of death from all causes.
Conclusions
The level of circulating CD34+KDR+ endothelial progenitor cells predicts the occurrence of cardiovascular events and death from cardiovascular causes and may help to identify patients at increased cardiovascular risk.
Media in This Article
Figure 1
Cumulative Event-free Survival in an Analysis of Death from Cardiovascular Causes at 12 Months, According to Levels of Circulating CD34+KDR+ Endothelial Progenitor Cells at the Time of Enrollment.Figure 2
Cumulative Event-free Survival in Analysis of a First Major Cardiovascular Event (Myocardial Infarction, Hospitalization, Revascularization, or Cardiovascular Death) at 12 Months, According to Levels of Circulating CD34+KDR+ Endothelial Progenitor Cells at the Time of Enrollment.Article Activity
- Article
Coronary artery disease results from a chronic inflammatory disease of the vascular wall and leads to vessel occlusion and organ damage.1 Despite intense efforts to determine the pathogenesis of atherosclerosis, this process remains poorly understood. Reports suggest that risk factors and a genetic predisposition together induce inflammatory processes that lead to cell damage and impair regeneration within the vessel wall.2,3 Since resident endothelial cells infrequently proliferate,4 it has been postulated that there are other sources of vascular replenishment in response to continuous damage.5 Endothelial progenitor cells derived from bone marrow circulate in the peripheral blood and have been implicated in neoangiogenesis after tissue ischemia has occurred.6-9 Endothelial progenitor cells are capable of proliferating and differentiating into endothelial cells and are therefore ideal candidates for vascular regeneration.10,11 Experiments in animals show that the systemic application or mobilization of stem cells and progenitor cells beneficially influences the repair of endothelial cells after injury and the progression of atherosclerosis.12-18 In humans, the role of endothelial progenitor cells is less clear. Intracoronary injection of endothelial progenitor cells may improve left ventricular function after acute myocardial infarction.19-21 In addition, the accumulation of cardiovascular risk factors or an increased overall risk is associated with dysfunction and decreased numbers of endothelial progenitor cells.22,23
Although these data suggest that there is a close interplay between endothelial progenitor cells and cardiovascular risk factors, the exact role of these cells in the pathogenesis of coronary artery disease remains to be determined. It is unknown whether the number of endothelial progenitor cells relates to outcomes in patients with coronary artery disease. In order to test this hypothesis, we assessed the number of endothelial progenitor cells in patients with coronary artery disease and prospectively analyzed cardiovascular outcomes during a follow-up period of 12 months.
Methods
Study Population
Between March 2003 and January 2004, 587 patients who consecutively underwent coronary angiography were screened for inclusion in the Endothelial Progenitor Cells in Coronary Artery Disease study. Forty-nine patients without signs of coronary artery disease on angiography and 19 patients with malignant, inflammatory diseases or severe acute ischemia other than myocardial ischemia were excluded from the study. Informed consent was obtained from all patients, and the study protocol was approved by the ethics committee of the University of Saarland. The investigators initiated the study, had full access to and analyzed the data, and wrote the manuscript. All authors vouch for the data and analysis.
Angiography
Cardiac catheterization was performed according to the guidelines for coronary angiography of the American College of Cardiology and the American Heart Association.24 Biplane ventriculography was performed in standard projections. The ejection fraction was calculated by dividing the end-diastolic and end-systolic left ventricular areas with the use of an automated computer system (Digital Cardiac Imaging software, Philips). The extent of coronary artery disease was scored, by at least two independent interventional cardiologists, as 0 (stenosis <50 percent), 1 (stenosis of any main coronary artery ≥50 percent), 2 (stenosis of two main coronary arteries ≥50 percent), and 3 (stenosis of three main coronary arteries ≥50 percent).
Previous Events, Follow-up, and Causes of Death
The classification of previous events and follow-up data was made on the basis of medical records and personal interviews. Causes of death were determined by examination of hospital records, autopsy reports, and medical files of the patients' general practitioners. Deaths due to cardiovascular causes included sudden deaths and deaths from acute myocardial infarction, coronary artery disease, or congestive heart failure.
Preparation of Blood Samples
Arterial blood was drawn from the femoral artery and buffered with 20 ml of sodium citrate before cardiac catheterization. Mononuclear cells were isolated with the use of a Ficoll density gradient (Biocoll, Biochrom) according to standard protocols. Additional blood samples were obtained for routine analyses.
Flow Cytometry
For fluorescence-activated cell-sorting analysis, mononuclear cells were resuspended in 100 μl of a fluorescence-activated cell-sorting buffer containing phosphate-buffered saline, 0.1 percent bovine albumin, and aprotinin (20 μl per milliliter). Immunofluorescent cell staining was performed with the use of the fluorescent conjugated antibody CD34–fluorescein isothiocyanate (FITC) (10 μl; Becton Dickinson), KDR (kinase insert domain receptor), and CD133–phycoerythrin (PE) (10 μl; Miltenyi). For the identification of KDR+ cells, indirect immunolabeling was performed with the use of a biotinylated goat mononuclear antibody against the extracellular domain of human KDR (R&D Systems). IgG2a–FITC–PE antibody (Becton Dickinson) served as a negative control. For staining of KDR, extensive blocking was required with the use of human immunoglobulin (polyglobulin, 10 percent; Bayer) and goat serum (Sigma-Aldrich). Cell fluorescence was measured immediately after staining, and data were analyzed with the use of CellQuest software (FACSCalibur, Becton Dickinson). Units of all measured components are absolute cell counts obtained after the measurement of 10,000 events in the lymphocyte gate. To assess the reproducibility of the measurements, two separate blood samples were obtained, on days 0 and 7, from 10 subjects. The intraclass correlation between the two probes was 0.94. Probes were measured at the same time of day, with identical instrument settings, by two investigators. For each patient, a corresponding negative control with IgG2a–FITC–PE antibody was obtained.
Colony-Forming Units of Endothelial Cells
In an endothelial basal medium (CellSystems) with supplements, 1×107 mononuclear cells were seeded on human fibronectin–coated plates (Sigma-Aldrich). After 48 hours, 1×106 nonadherent cells were transferred into new fibronectin-coated wells to avoid contamination with mature endothelial cells and nonprogenitor cells.22 After seven days in vitro, endothelial colony-forming units in at least three wells were counted by two independent investigators. Colony-forming units of endothelial cells are expressed as absolute numbers of colonies per well.
Statistical Analysis
The association between baseline levels of endothelial progenitor cells and the following prespecified end points was evaluated after 12 months: death from cardiovascular causes, the occurrence of a first major cardiovascular event (acute myocardial infarction, hospitalization due to cardiovascular events, revascularization, or death from cardiovascular causes), the need for revascularization, hospitalization due to cardiovascular events, and death from any cause. Levels of endothelial progenitor cells were analyzed as categorical variables after log transformation (on a base 10 scale) to normalize distribution. In categorical analyses, we used prespecified thresholds corresponding to patients' endothelial progenitor-cell counts (low, medium, and high) at the time of enrollment. Continuous variables were tested for normal distribution with the use of the Kolmogorov–Smirnov test. Means between two categories were compared with the use of a two-tailed, unpaired Student's t-test. The one-way analysis-of-variance test was used for comparisons of categorical variables. For post hoc analysis, the Bonferroni correction was applied. A multivariate proportional-hazards regression analysis was performed to determine the association between endothelial progenitor-cell counts and each outcome. Analyses were adjusted for age; sex; smoking status; the presence of hypertension, diabetes, or hyperlipidemia; left ventricular ejection fraction; percutanous coronary intervention; a diagnosis of an acute coronary syndrome at the time of enrollment; the severity of coronary artery disease; and treatment with angiotensin-converting–enzyme (ACE) inhibitors, beta-blockers, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins), and platelet inhibitors. The hazard ratio represents the predicted change in the hazard for a unit increase in the predictor (e.g., an increase from low to medium or from medium to high in the number of endothelial progenitor cells). Survival was determined with the use of the Kaplan–Meier method and the Cox regression analysis. The log-rank test was used to determine statistical differences in terms of survival. Statistical significance was assumed when a null hypothesis could be rejected at P<0.05. Statistical analysis was performed with the use of SPSS software, version 11.5, for Windows.
All data analyses and event classifications were performed by investigators blinded to the endothelial progenitor-cell status of the patients.
Results
Baseline Characteristics
A total of 519 patients with coronary artery disease as diagnosed on angiography were enrolled. Of these, 12 patients (2.3 percent) were lost to follow-up. The mean (±SD) age of the remaining 507 patients was 66.6±10.8 years (range, 30 to 87). Detailed characteristics of the patients are listed in Table 1Table 1
Baseline Characteristics of the Patients..Endothelial Progenitor-Cell Counts and Baseline Clinical Variables
The number of endothelial progenitor cells ranged from 12 to 1039 CD34+KDR+ cells, with a mean of 86.3±71.9. After logarithmic transformation (base 10), endothelial progenitor-cell counts were categorized into three groups according to the cell count at the time of enrollment (Table 1). Group 1 represents patients with log numbers of endothelial progenitor cells of 1.71 or less, group 2 patients with log numbers between 1.72 and 1.96, and group 3 patients with log numbers between 1.97 and 3.02.
In univariate analyses, smoking, diuretic therapy, and statin therapy were associated with high baseline levels of CD34+KDR+ endothelial progenitor cells (P=0.02, P=0.007, and P=0.05, respectively), whereas low levels were associated with a high left ventricular ejection fraction and treatment with angiotensin-receptor blockers (P=0.008 and P=0.03, respectively) (Table 1). In addition to CD34+KDR+ endothelial progenitor cells, we measured CD133+ cells, which resemble a subfraction of immature endothelial progenitor cells. Therapy with statins and ACE inhibitors was associated with high baseline levels of CD133+ cells (P=0.01 and P=0.03, respectively), whereas low levels were associated with increased low-density lipoprotein (LDL) cholesterol levels, advanced age, and high systolic blood pressure (P=0.01, P<0.001, and P=0.008, respectively).
In order to determine the functional capacity of circulating endothelial progenitor cells, we measured the number of colony-forming units of endothelial cells in a subgroup of 203 patients. Therapy with statins and ACE inhibitors was associated with increased numbers of colony-forming units of endothelial cells (P=0.001 and P=0.03, respectively), whereas reduced numbers of colony-forming units of endothelial cells were associated with increased LDL cholesterol levels, advanced age, diabetes, smoking, and a family history of premature coronary artery disease (P=0.01, P=0.002, P=0.01, P=0.002, and P=0.004, respectively).
Incidence of Death and Cardiovascular Events
Table 2Table 2
Number of Events at 12 Months of Follow-up. shows the incidence of outcomes during the 12 months of follow-up. A total of 43 patients (8.5 percent) died, 23 from cardiovascular causes (4.5 percent); other causes included sepsis (9 patients), chronic renal insufficiency (3), pneumonia (4), and cerebral bleeding (3). In one patient, the cause of death remained unclassified. Thirty-four patients (6.7 percent) had acute myocardial infarction, 163 (32.1 percent) required revascularization, and 186 (36.7 percent) were admitted to a hospital owing to cardiovascular events.In univariate analyses, the incidence of death from cardiovascular causes was significantly influenced by advanced age (hazard ratio, 1.07; 95 percent confidence interval, 1.01 to 1.12; P=0.01), low left ventricular ejection fraction (hazard ratio, 0.96; 95 percent confidence interval, 0.94 to 0.99; P=0.004), concomitant treatment with beta-blockers (hazard ratio, 3.38; 95 percent confidence interval, 1.01 to 11.43; P=0.05), and a low level of circulating endothelial progenitor cells (hazard ratio, 0.45; 95 percent confidence interval, 0.25 to 0.81; P=0.007).
A multivariate regression analysis identified advanced age, low left ventricular ejection fraction, and a low level of circulating endothelial progenitor cells as the only independent predictors of death from cardiovascular causes. The occurrence of a first major cardiovascular event was significantly influenced by a greater severity of coronary artery disease (hazard ratio, 1.52; 95 percent confidence interval, 1.31 to 1.76; P<0.001), coronary intervention (hazard ratio, 1.57; 95 percent confidence interval, 1.20 to 2.06; P=0.001), a diagnosis of an acute coronary syndrome (hazard ratio, 1.51; 95 percent confidence interval, 1.13 to 2.02; P=0.006) or subacute myocardial infarction (hazard ratio, 1.57; 95 percent confidence interval, 1.03 to 2.40; P=0.04) at the time of enrollment, and a low level of circulating endothelial progenitor cells (hazard ratio, 0.72; 95 percent confidence interval, 0.61 to 0.86; P<0.001). In a multivariate analysis, the degree of coronary artery disease and the level of circulating endothelial progenitor cells were mutually independent predictors of the occurrence of a first major cardiovascular event.
Endothelial Progenitor-Cell Levels and Clinical Outcomes
Cumulative event-free survival increased in a stepwise fashion across increasing levels of baseline endothelial progenitor cells in analyses of death from cardiovascular causes (P=0.01) and a first major cardiovascular event (P<0.001) (Figure 1Figure 1
Cumulative Event-free Survival in an Analysis of Death from Cardiovascular Causes at 12 Months, According to Levels of Circulating CD34+KDR+ Endothelial Progenitor Cells at the Time of Enrollment. and Figure 2Figure 2Cumulative Event-free Survival in Analysis of a First Major Cardiovascular Event (Myocardial Infarction, Hospitalization, Revascularization, or Cardiovascular Death) at 12 Months, According to Levels of Circulating CD34+KDR+ Endothelial Progenitor Cells at the Time of Enrollment.). Revascularization (P<0.001) and hospitalization (P=0.001) were significantly more frequent among patients with lower levels of endothelial progenitor cells than among those with higher levels.Increasing levels of CD34+KDR+ endothelial progenitor cells were associated with a decreased risk of death from cardiovascular causes (Table 3Table 3
Multivariate Analysis of the Association between Increasing Levels of CD34+KDR+ Endothelial Progenitor Cells and Outcomes.). The risk of death from cardiovascular causes was increased by a factor of more than three among patients with low endothelial progenitor-cell levels, as compared with patients with high levels. After adjustment for age, sex, cardiovascular risk factors, concomitant drug therapy, the severity of coronary artery disease, left ventricular ejection fraction, percutaneous coronary intervention, and a diagnosis of acute coronary syndrome, the association between increasing levels of endothelial progenitors and a decreased risk of death from cardiovascular causes remained significant (P=0.001) (Table 3). Decreasing endothelial progenitor-cell levels were associated with the development of a first major cardiovascular event. A multivariate analysis with adjustment for covariates confirmed a significant association between CD34+KDR+ endothelial progenitor-cell levels and the occurrence of a first major cardiovascular event (hazard ratio, 0.74; 95 percent confidence interval, 0.62 to 0.89; P=0.002) (Table 3). In multivariate analyses, the rates of revascularization and hospitalization due to cardiovascular causes were significantly decreased among patients with high levels of circulating endothelial progenitor cells (hazard ratio for revascularization, 0.77; 95 percent confidence interval, 0.62 to 0.95; P=0.02; and hazard ratio for hospitalization, 0.76; 95 percent confidence interval, 0.63 to 0.94; P=0.01). No significant association was detected between endothelial progenitor-cell levels and acute myocardial infarction and death from any cause.Cumulative event-free survival increased in stepwise fashion with increasing baseline CD133+ endothelial progenitor-cell levels in an analysis of death from cardiovascular causes (P=0.03 by the log-rank test), a first major cardiovascular event (P=0.04), and hospitalization (P=0.04) (Figure 1 of the Supplementary Appendix, available with the full text of this article at www.nejm.org). In a multivariate analysis, the association between increasing CD133+ endothelial progenitor-cell levels and reduced risks of a first major cardiovascular event (hazard ratio, 0.81; 95 percent confidence interval, 0.66 to 0.98; P=0.03) and hospitalization (hazard ratio, 0.75; 95 percent confidence interval, 0.61 to 0.93; P=0.007) remained significant.
Cumulative event-free survival increased in stepwise fashion with increasing baseline levels of colony-forming units of endothelial cells in an analysis of a first major cardiovascular event (P=0.03), revascularization (P=0.01), and hospitalization (P=0.01) (Figure 2 of the Supplementary Appendix). A multivariate analysis confirmed a significant association between increasing numbers of colony-forming units and decreased risks of a first major cardiovascular event (hazard ratio, 0.68; 95 percent confidence interval, 0.49 to 0.96; P=0.03), revascularization (hazard ratio, 0.58; 95 percent confidence interval, 0.38 to 0.88; P=0.01), and hospitalization (hazard ratio, 0.59; 95 percent confidence interval, 0.41 to 0.85; P=0.004).
Discussion
Experimental and clinical studies suggest that there is an evolving role for endothelial progenitor cells in neoangiogenesis and rejuvenation of the endothelial monolayer.6,12,17 The presence of immature circulating cells in the peripheral blood has been advocated as a marker of an organism's regenerative capacity,25 and current trials of therapy aim to increase the number of progenitor cells at the site of tissue damage.19-21 Despite numerous studies, the role of endothelial progenitor cells as a prognostic marker is unclear. Various serum markers have been identified that predict mortality and morbidity due to cardiovascular causes.26-30 In contrast to the measurement of a single serum marker for the prediction of risk, use of a cellular marker of risk, such as the level of endothelial progenitor cells, unifies the complex interactions of multiple negative factors and may yield a better picture of in vivo mechanisms. In this prospective study, we demonstrated that a single measurement of CD34+KDR+ endothelial progenitor cells is a useful tool to predict cardiovascular outcomes in patients with coronary artery disease. During the observational period of 12 months, a significantly higher incidence of death from cardiovascular causes was observed in patients with low baseline levels of endothelial progenitor cells. The association between these levels and death from cardiovascular causes was independent of the severity of coronary artery disease, a diagnosis of an acute coronary syndrome at the time of enrollment, cardiovascular risk factors, and drug therapy known to influence cardiovascular outcomes.
The occurrence of a first major cardiovascular event (acute myocardial infarction, hospitalization, revascularization, or death from cardiovascular causes) was associated with reduced endothelial progenitor-cell levels. Analyses of the prespecified single end points revealed that hospitalization, the need for revascularization, and to a lesser extent, the rate of death from cardiovascular causes were the major factors for the prediction of end points.
Studies in animals suggest that enhancement of the number of circulating endothelial progenitor cells through exercise training, statin therapy, or estrogen therapy improves the replenishment of the endothelial monolayer by endothelial progenitor cells after vascular injury and — due to enhanced restoration of the endothelial monolayer — diminishes neointima formation.14,16,31-33 In humans, a small-scale study suggests that there is a higher incidence of restenosis in patients with reduced levels of circulating endothelial progenitor cells than in patients with increased numbers.34 In our study, we demonstrated that patients with high numbers of endothelial progenitor cells had a reduced risk of revascularization. These findings suggest that endothelial progenitor cells contribute to the restoration of the endothelial monolayer, as suggested by data from experimental studies.
Endothelial progenitor-cell levels were not predictive of death from all causes, acute myocardial infarction, or stroke. This finding may suggest that there was an excess of deaths from noncardiovascular causes among patients with increased endothelial progenitor-cell levels. However, no excess of particular noncardiovascular causes of death were identifiable (data not shown). Small-scale studies suggest that after acute myocardial infarction, the numbers of circulating CD34+ and CD133+KDR+ endothelial progenitor cells are up-regulated in response to tissue ischemia.3,35 Given the results of our study, we have to assume that the role of endothelial progenitor cells in acute myocardial infarction or stroke is more complex than was initially expected. In our study, endothelial progenitor cells that were mobilized after acute myocardial infarction were functionally impaired (data not shown). This is in accordance with the finding that in patients with congestive heart failure, there is impaired function of progenitor cells.36 At present, the pathophysiologic consequences of this dysfunction are unknown. Further studies are needed to elucidate the exact role of endothelial progenitor cells in acute myocardial infarction.
In addition to CD34+KDR+ endothelial progenitor cells, we measured the numbers of immature CD133+ cells, which also correlated with cardiovascular outcomes. In order to determine the functional properties of formerly circulating endothelial progenitor cells, we determined the number of endothelial colony-forming units in a subgroup of patients. We confirmed and extended the findings of Hill et al.,22 demonstrating that functional properties of endothelial progenitor cells influence cardiovascular outcomes.
Our results suggest that circulating endothelial progenitor cells in patients with coronary artery disease can be used to identify patients at high risk for major adverse cardiac events. This finding supports the notion that immature cells play an important part in the pathogenesis of atherosclerotic disease and that the measurement of endothelial progenitor cells may improve risk stratification. Further studies assessing the therapeutic targeting of circulating endothelial progenitor cells are warranted to prove the underlying biologic concept that endothelial-cell regeneration through circulating endothelial progenitor cells is necessary for vascular healing.
Supported by Deutsche Forschungsgemeinschaft and by a grant (LSHM-CT-2003-503254) from the European Vascular Genomics Network of the European Commission.
We are indebted to Sybille Richter and Simone Jäger for outstanding technical assistance and to Sven Wassmann for critical review of the manuscript.
Source Information
From the Division of Cardiology, Angiology, and Intensive Care Medicine, Department of Internal Medicine, University of Saarland, Homburg–Saar, Germany.
Address reprint requests to Dr. Nickenig at the Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, D-66421, Homburg–Saar, Germany, or at nickenig@med-in.uni-sb.de.
- References
References
1
Ross R . Atherosclerosis -- an inflammatory disease. N Engl J Med 1999;340:115-126
Full Text | Web of Science | Medline2
Choy JC ,Granville DJ ,Hunt DW ,McManus BM . Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001;33:1673-1690
CrossRef | Web of Science | Medline3
Gill M ,Dias S ,Hattori K , et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001;88:167-174
Web of Science | Medline4
Schwartz SM ,Benditt EP . Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 1976;73:651-653
CrossRef | Web of Science | Medline5
Op den Buijs J ,Musters M ,Verrips T ,Post JA ,Braam B ,van Riel N . Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 2004;287:H2651-8
CrossRef | Web of Science | Medline6
Asahara T ,Murohara T ,Sullivan A , et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967
CrossRef | Web of Science | Medline7
Kalka C ,Masuda H ,Takahashi T , et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-3427
CrossRef | Web of Science | Medline8
Kawamoto A ,Gwon HC ,Iwaguro H , et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-637
Web of Science | Medline9
Rafii S ,Lyden D . Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712
CrossRef | Web of Science | Medline10
Gehling UM ,Ergun S ,Schumacher U , et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106-3112
Web of Science | Medline11
Gunsilius E ,Duba HC ,Petzer AL ,Kahler CM ,Gastl GA . Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res 2001;88:E1-E1
Web of Science | Medline12
Kong D ,Melo LG ,Gnecchi M , et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004;110:2039-2046
CrossRef | Web of Science | Medline13
Nowak G ,Karrar A ,Holmen C , et al. Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 2004;110:3699-3707
CrossRef | Web of Science | Medline14
Strehlow K ,Werner N ,Berweiler J , et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107:3059-3065
CrossRef | Web of Science | Medline15
Walter DH ,Rittig K ,Bahlmann FH , et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-3024
CrossRef | Web of Science | Medline16
Werner N ,Priller J ,Laufs U , et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 2002;22:1567-1572
CrossRef | Web of Science | Medline17
Werner N ,Junk S ,Laufs U , et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:e17-e24
CrossRef | Web of Science | Medline18
Rauscher FM ,Goldschmidt-Clermont PJ ,Davis BH , et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108:457-463
CrossRef | Web of Science | Medline19
Assmus B ,Schachinger V ,Teupe C , et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017
CrossRef | Web of Science | Medline20
Strauer BE ,Brehm M ,Zeus T , et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918
CrossRef | Web of Science | Medline21
Wollert KC ,Meyer GP ,Lotz J , et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148
CrossRef | Web of Science | Medline22
Hill JM ,Zalos G ,Halcox JP , et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600
Full Text | Web of Science | Medline23
Vasa M ,Fichtlscherer S ,Aicher A , et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7
CrossRef | Web of Science | Medline24
Scanlon PJ ,Faxon DP ,Audet AM , et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999;33:1756-1824
CrossRef | Web of Science | Medline25
Blau HM ,Brazelton TR ,Weimann JM . The evolving concept of a stem cell: entity or function? Cell 2001;105:829-841
CrossRef | Web of Science | Medline26
Biasucci LM ,Vitelli A ,Liuzzo G , et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877
Web of Science | Medline27
Blankenberg S ,Rupprecht HJ ,Bickel C , et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003;349:1605-1613
Full Text | Web of Science | Medline28
Heeschen C ,Dimmeler S ,Hamm CW , et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-1111
Full Text | Web of Science | Medline29
Nygard O ,Nordrehaug JE ,Refsum H ,Ueland PM ,Farstad M ,Vollset SE . Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236
Full Text | Web of Science | Medline30
Ridker PM ,Hennekens CH ,Buring JE ,Rifai N . C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843
Full Text | Web of Science | Medline31
Dimmeler S ,Aicher A ,Vasa M , et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-397
Web of Science | Medline32
Laufs U ,Werner N ,Link A , et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109:220-226
CrossRef | Web of Science | Medline33
Rehman J ,Li J ,Parvathaneni L , et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004;43:2314-2318
CrossRef | Web of Science | Medline34
George J ,Herz I ,Goldstein E , et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003;23:e57-e60
CrossRef | Web of Science | Medline35
Shintani S ,Murohara T ,Ikeda H , et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779
CrossRef | Web of Science | Medline36
Heeschen C ,Lehmann R ,Honold J , et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-1622
CrossRef | Web of Science | Medline
- Citing Articles (544)
Citing Articles
1
K. Walenta, V. Schwarz, S. Schirmer, I. Kindermann, E. B. Friedrich, E. F. Solomayer, K. Sliwa, S. Labidi, D. Hilfiker-Kleiner, M. Bohm. (2012) Circulating microparticles as indicators of peripartum cardiomyopathy. European Heart Journal
CrossRef2
Ana Carolina Alba, Diego Hernan Delgado, Vivek Rao, Stephen Walter, Gordon Guyatt, Heather Joan Ross. (2012) Are endothelial progenitor cells a prognostic factor in patients with heart failure?. Expert Review of Cardiovascular Therapy 10:2, 167-175
CrossRef3
Dylan Burger, Rhian M. Touyz. (2012) Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. Journal of the American Society of Hypertension
CrossRef4
Brian D. Plouffe, Madhumita Mahalanabis, Laura H. Lewis, Catherine M. Klapperich, Shashi K. Murthy. (2012) Clinically Relevant Microfluidic Magnetophoretic Isolation of Rare-Cell Populations for Diagnostic and Therapeutic Monitoring Applications. Analytical Chemistry120127091515008
CrossRef5
Menake E. Piyasena, Pearlson P. Austin Suthanthiraraj, Robert W. Applegate, Andrew M. Goumas, Travis A Woods, Gabriel P. Lopez, Steven W. Graves. (2012) Multinode acoustic focusing for parallel flow cytometry. Analytical Chemistry120112100438003
CrossRef6
Stella Bernardi, Giovanni Maria Severini, Giorgio Zauli, Paola Secchiero. (2012) Cell-Based Therapies for Diabetic Complications. Experimental Diabetes Research 2012, 1-10
CrossRef7
Sridevi Devaraj, Ishwarlal Jialal. (2012) Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome. Experimental Diabetes Research 2012, 1-5
CrossRef8
Haiyang Zhang, Maarten Albersen, Xunbo Jin, Guiting Lin. (2012) Stem cells: novel players in the treatment of erectile dysfunction. Asian Journal of Andrology 14:1, 145-155
CrossRef9
Eugenia Rosa Nuzzolo, Maria Grazia Iachininoto, Luciana Teofili. (2012) Endothelial progenitor cells and thrombosis. Thrombosis Research
CrossRef10
Bingsheng Huang, Ying Cheng, Qiang Xie, Guixiong Lin, Yuyan Wu, Yanling Feng, Jinxiong Gao, Dingli Xu. (2012) Effect of 40 mg Versus 10 mg of Atorvastatin on Oxidized Low-Density Lipoprotein, High-Sensitivity C-Reactive Protein, Circulating Endothelial-Derived Microparticles, and Endothelial Progenitor Cells in Patients With Ischemic Cardiomyopathy. Clinical Cardiologyn/a-n/a
CrossRef11
Jianfei Chen, Jun Jing, Minbao Song, Hongmei Dong, Gan Zhao, Lan Huang. (2012) C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products. Gene
CrossRef12
CHRISTIAN JUNG, PEDER SÖRENSSON, NAWSAD SALEH, HÅKAN ARHEDEN, LARS RYDÉN, JOHN PERNOW. (2012) Effects of Myocardial Postconditioning on the Recruitment of Endothelial Progenitor Cells. Journal of Interventional Cardiologyno-no
CrossRef13
Patrick Allen, Joyce Bischoff. 2011. Building Blood Vessels Using Endothelial and Mesenchymal Progenitor Cells. , 31-54.
CrossRef14
Johannes C Grisar, Francois Haddad, Fatemeh A Gomari, Joseph C Wu. (2011) Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomarkers in Medicine 5:6, 731-744
CrossRef15
A. Gonçalves, E. Leal, A. Paiva, E. Teixeira Lemos, F. Teixeira, C. F. Ribeiro, F. Reis, A. F. Ambrósio, R. Fernandes. (2011) Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. Diabetes, Obesity and Metabolismno-no
CrossRef16
Matteo Pirro, Elena Bartoloni Bocci, Francesco Di Filippo, Giuseppe Schillaci, Massimo Raffaele Mannarino, Francesco Bagaglia, Roberto Gerli, Elmo Mannarino. (2011) Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. Journal of Internal Medicineno-no
CrossRef17
Çağdaş Baran, Serkan Durdu, Klara Dalva, Çagın Zaim, Arın Dogan, Gokhan Ocakoglu, Günhan Gürman, Önder Arslan, Ahmet Rüçhan Akar. (2011) Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial. Stem Cell Reviews and Reports
CrossRef18
Jean-Jacques Boffa, Sophie Chauvet, Fabrice Mihout. (2011) Ralentir la progression de l’insuffisance rénale chronique : espoirs et déceptions. La réparation vasculaire du rein chronique. La Presse Médicale 40:11, 1065-1073
CrossRef19
Christine Cheung, Sanjay Sinha. (2011) Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. Journal of Molecular and Cellular Cardiology 51:5, 651-664
CrossRef20
Kaihong Yi, Min Yu, Libiao Wu, Xuerui Tan. (2011) Effects of urotensin II on functional activity of late endothelial progenitor cells. Peptides
CrossRef21
Wen-Hao Xia, Jing Li, Chen Su, Zhen Yang, Long Chen, Fang Wu, Yuan-Yuan Zhang, Bing-Bo Yu, Yan-Xia Qiu, Shen-Ming Wang, Jun Tao. (2011) Physical exercise attenuates age-associated reduction in endothelium-reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK-2 signaling in healthy men. Aging Cellno-no
CrossRef22
David M. Smadja, Jean-Paul Duong-van-Huyen, Liliane Dal Cortivo, Anne Blanchard, Patrick Bruneval, Joseph Emmerich, Pascale Gaussem. (2011) Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia. Cytotherapy1-8
CrossRef23
G Rath, R Tripathi. (2011) Angiogenic balance and diagnosis of pre-eclampsia: selecting the right VEGF receptor. Journal of Human Hypertension
CrossRef24
Miriam Puls, Marco R. Schroeter, Jasmin Steier, Lena Stijohann, Gerd Hasenfuss, Stavros Konstantinides, Katrin Schäfer. (2011) Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells. International Journal of Cardiology 152:1, 61-69
CrossRef25
Dimitris Tousoulis, Ioannis Andreou, Charalambos Antoniades, Gerasimos Siasos, Pavlos Stougiannos, Athanasios Trikas, Christodoulos Stefanadis. (2011) Do endothelial progenitor cells modify our strategy to treat risk factors?. International Journal of Cardiology 152:1, 95-97
CrossRef26
Georg Hansmann, Brian D. Plouffe, Adam Hatch, Alexander Gise, Hannes Sallmon, Roham T. Zamanian, Shashi K. Murthy. (2011) Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension. Journal of Molecular Medicine 89:10, 971-983
CrossRef27
Damian O. McCall, Michelle C. McKinley, Rebecca Noad, Pascal P. McKeown, David R. McCance, Ian S. Young, Jayne V. Woodside. (2011) The assessment of vascular function during dietary intervention trials in human subjects. British Journal of Nutrition 106:07, 981-994
CrossRef28
David M. Leistner, Ulrich Fischer-Rasokat, Jörg Honold, Florian H. Seeger, Volker Schächinger, Ralf Lehmann, Hans Martin, Iris Burck, Carmen Urbich, Stefanie Dimmeler, Andreas M. Zeiher, Birgit Assmus. (2011) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clinical Research in Cardiology 100:10, 925-934
CrossRef29
Nuno Bettencourt, Susana Oliveira, Andre Michael Toschke, João Rocha, Daniel Leite, Mónica Carvalho, Sónia Xará, Andreas Schuster, Amedeo Chiribiri, Adelino Leite-Moreira, Eike Nagel, Helena Alves, Vasco Gama. (2011) Predictors of circulating endothelial progenitor cell levels in patients without known coronary artery disease referred for multidetector computed tomography coronary angiography. Revista Portuguesa de Cardiologia 30:10, 753-760
CrossRef30
Nuno Bettencourt, Susana Oliveira, Andre Michael Toschke, João Rocha, Daniel Leite, Mónica Carvalho, Sónia Xará, Andreas Schuster, Amedeo Chiribiri, Adelino Leite-Moreira, Eike Nagel, Helena Alves, Vasco Gama. (2011) Predictors of circulating endothelial progenitor cell levels in patients without known coronary artery disease referred for multidetector computed tomography coronary angiography. Revista Portuguesa de Cardiologia (English Edition) 30:10, 753-760
CrossRef31
Susan Cheng, Na Wang, Martin G. Larson, Joseph N. Palmisano, Gary F. Mitchell, Emelia J. Benjamin, Ramachandran S. Vasan, Daniel Levy, Elizabeth L. McCabe, Joseph A. Vita, Thomas J. Wang, Stanley Y. Shaw, Kenneth S. Cohen, Naomi M. Hamburg. (2011) Circulating angiogenic cell populations, vascular function, and arterial stiffness. Atherosclerosis
CrossRef32
Noboru Toda. (2011) Age-related changes in endothelial function and blood flow regulation. Pharmacology & Therapeutics
CrossRef33
Zhengang Zhang, Jianhua Qun, Chunmei Cao, Jun Wang, Wei Li, Yong Wu, Lin Du, Pei Zhao, Kaizheng Gong. (2011) Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway. Molecular Biology Reports
CrossRef34
Mariola López, Eugenia Vispo, Jesús San Román, Dolores Herrero, Alejandra Peris, Angelica Corral, Vicente Soriano, Jose Miguel Benito. (2011) High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells. AIDS Research and Human Retroviruses110921085045002
CrossRef35
Ching-Wei Lee, Po-Hsun Huang, Shao-Sung Huang, Hsin-Bang Leu, Chin-Chou Huang, Tao-Cheng Wu, Jaw-Wen Chen, Shing-Jong Lin. (2011) Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy. Hypertension Research 34:9, 999-1003
CrossRef36
T. Wurster, K. Stellos, T. Geisler, P. Seizer, M. E. Andia, A. Schuster, A. E. May, A. Melms, M. Gawaz, B. Bigalke. (2011) Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?. European Journal of Neurologyno-no
CrossRef37
De-guang Yang, Ling Liu, Sheng-hua Zhou, Mei-fang Ma, Tie Wen. (2011) Remnant-Like Lipoproteins May Accelerate Endothelial Progenitor Cells Senescence Through Inhibiting Telomerase Activity via the Reactive Oxygen Species-Dependent Pathway. Canadian Journal of Cardiology 27:5, 628-634
CrossRef38
Toshio Imanishi. (2011) Potential mechanisms in angiotensin II-induced EPCs senescence. Hypertension Research 34:9, 989-990
CrossRef39
I. Ahrens, H. Domeij, S. U. Eisenhardt, D. Topcic, M. Albrecht, E. Leitner, K. Viitaniemi, J. B. Jowett, M. Lappas, C. Bode, I. Haviv, K. Peter. (2011) Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Research in Cardiology 106:5, 879-895
CrossRef40
Li Dong, Lina Kang, Liang Ding, Qin Chen, Jian Bai, Rong Gu, Lixin Li, Biao Xu. (2011) Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. Microvascular Research
CrossRef41
Xavier Freixa, Monica Masotti, Marta Palomo, Maribel Diaz-Ricart, Ginés Escolar, Eduard Guasch, Ander Regueiro, Marcelo Jiménez, Amadeo Betriu, Magda Heras. (2011) Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction. Microvascular Research 82:2, 177-181
CrossRef42
Lorenzo A Calò, Monica Facco, Paul A Davis, Elisa Pagnin, Lucia Dal Maso, Massimo Puato, Paola Caielli, Carlo Agostini, Achille C Pessina. (2011) Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Hypertension Research 34:9, 1017-1022
CrossRef43
R. Goekmen Turan, I. Bozdag-T, J. Ortak, S. Kische, I. Akin, H. Schneider, C. H. Turan, T. C. Rehders, M. Rauchhaus, T. Kleinfeldt, C. Belu, M. Brehm, S. Yokus, S. Steiner, K. Sahin, C. A. Nienaber, H. Ince. (2011) Improved Functional Activity of Bone Marrow Derived Circulating Progenitor Cells After Intra Coronary Freshly Isolated Bone Marrow Cells Transplantation in Patients with Ischemic Heart Disease. Stem Cell Reviews and Reports 7:3, 646-656
CrossRef44
Delfin Rodriguez Leyva, Peter Zahradka, Bram Ramjiawan, Randy Guzman, Michel Aliani, Grant N. Pierce. (2011) The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease. Contemporary Clinical Trials 32:5, 724-730
CrossRef45
Ramazan Gökmen Turan, Ilkay Bozdag-Turan, Jasmin Ortak, Ibrahim Akin, Stephan Kische, Henrik Schneider, Cem Hakan Turan, Tim Christopher Rehders, Mathias Rauchhaus, Tilo Kleinfeldt, Ester Adolph, Micheal Brehm, Sedat Yokus, Stephan Steiner, Kurtulus Sahin, Christoph A. Nienaber, Hüseyin Ince. (2011) Improved Mobilization of the CD34 + and CD133 + Bone Marrow-Derived Circulating Progenitor Cells by Freshly Isolated Intracoronary Bone Marrow Cell Transplantation in Patients with Ischemic Heart Disease. Stem Cells and Development 20:9, 1491-1501
CrossRef46
M. W. Laschke, C. Giebels, M. D. Menger. (2011) Vasculogenesis: a new piece of the endometriosis puzzle. Human Reproduction Update 17:5, 628-636
CrossRef47
Lale Tokgözoğlu, Hikmet Yorgun, Kadri Murat Gürses, Uğur Canpolat, Ahmet Hakan Ateş, Erol Tülümen, Ergün Barış Kaya, Kudret Aytemir, Giray Kabakçı, Murat Tuncer, Ali Oto. (2011) The association between circulating endothelial progenitor cells and coronary collateral formation. Atherosclerosis
CrossRef48
T. Dohi, K. Miyauchi, S. Okazaki, T. Yokoyama, H. Tamura, T. Kojima, K. Yokoyama, T. Kurata, H. Daida. (2011) Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Nephrology Dialysis Transplantation 26:9, 2906-2911
CrossRef49
Thomas Thum, Volker Wiebking, Georg Ertl, Johann Bauersachs. (2011) Organic Nitrates Differentially Modulate Circulating Endothelial Progenitor Cells and Endothelial Function in Patients with Symptomatic Coronary Artery Disease. Antioxidants & Redox Signaling 15:4, 925-931
CrossRef50
Hendrik Gremmels, Joost O. Fledderus, Bas W.M. van Balkom, Marianne C. Verhaar. (2011) Transcriptome Analysis in Endothelial Progenitor Cell Biology. Antioxidants & Redox Signaling 15:4, 1029-1042
CrossRef51
Ralf P. Brandes, Masuko Ushio-Fukai. (2011) Endothelial Progenitor Cells=EPC=Elemental Pernicious Complexity. Antioxidants & Redox Signaling 15:4, 911-914
CrossRef52
Felix Fleissner, Thomas Thum. (2011) Critical Role of the Nitric Oxide/Reactive Oxygen Species Balance in Endothelial Progenitor Dysfunction. Antioxidants & Redox Signaling 15:4, 933-948
CrossRef53
Sven Moebius-Winkler, Gerhard Schuler, Volker Adams. (2011) Endothelial Progenitor Cells and Exercise-Induced Redox Regulation. Antioxidants & Redox Signaling 15:4, 997-1011
CrossRef54
J.-M. Sinning, J. Losch, K. Walenta, M. Bohm, G. Nickenig, N. Werner. (2011) Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. European Heart Journal 32:16, 2034-2041
CrossRef55
Yiu-fai Cheung, Shing Chan, Mo Yang, Jie-yu Ye, Shau-yin Ha, Sophia J. Wong, Godfrey Chi-fung Chan. (2011) Circulating CD133+VEGFR2+ and CD34+VEGFR2+ cells and arterial function in patients with beta-thalassaemia major. Annals of Hematology
CrossRef56
Sebastian Schlaweck, Sebastian Zimmer, Rafael Struck, Eva Bartok, Nikos Werner, Franz Bauernfeind, Eicke Latz, Georg Nickenig, Veit Hornung, Alexander Ghanem. (2011) Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair. Biochemical and Biophysical Research Communications 411:3, 627-631
CrossRef57
Nobuhisa Nakamura, Keiko Naruse, Yasuko Kobayashi, Takashi Matsuki, Yoji Hamada, Eitaro Nakashima, Hideki Kamiya, Masaki Hata, Toru Nishikawa, Atsushi Enomoto, Masahide Takahashi, Toyoaki Murohara, Tatsuaki Matsubara, Yutaka Oiso, Jiro Nakamura. (2011) High glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt. Journal of Diabetes Investigation 2:4, 262-270
CrossRef58
Rainer Rauramaa, Maija Hassinen. (2011) Exercise Training and Endothelial Function. Current Cardiovascular Risk Reports 5:4, 323-330
CrossRef59
Giuseppe Gritti, Agostino Cortelezzi, Paolo Bucciarelli, Francesca Rezzonico, Silvia Lonati, Silvia La Marca, Ilaria Silvestris, Augusto B. Federici. (2011) Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis. American Journal of Hematology 86:8, 650-656
CrossRef60
W Wojakowski, U Landmesser, R Bachowski, T Jadczyk, M Tendera. (2011) Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia
CrossRef61
Po-Hsun Huang, Jia-Shiong Chen, Hsiao-Ya Tsai, Yung-Hsiang Chen, Feng-Yen Lin, Hsin-Bang Leu, Tao-Cheng Wu, Shing-Jong Lin, Jaw-Wen Chen. (2011) Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. Journal of Molecular and Cellular Cardiology 51:1, 109-119
CrossRef62
K Esposito, D Giugliano. (2011) Obesity, the Metabolic Syndrome, and Sexual Dysfunction in Men. Clinical Pharmacology & Therapeutics 90:1, 169-173
CrossRef63
Eric Parietti, Jean-René Pallandre, Frederic Deschaseaux, Bertrand Aupècle, Camille Durst, Jean-Pierre Kantelip, Sidney Chocron, Siamak Davani. (2011) Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1α are associated with ascending aorta aneurysm size. European Journal of Cardio-Thoracic Surgery 40:1, e6-e12
CrossRef64
Giuseppe Mandraffino, Maria A Sardo, Stefania Riggio, Saverio Loddo, Egidio Imbalzano, Angela Alibrandi, Carlo Saitta, Maurizio Cinquegrani, Enrico M Mormina, Antonino Saitta. (2011) Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertension Research 34:7, 876-883
CrossRef65
Min Yu, Qian Liu, Kaihong Yi, Libiao Wu, Xuerui Tan. (2011) Effects of osteopontin on functional activity of late endothelial progenitor cells. Journal of Cellular Biochemistry 112:7, 1730-1736
CrossRef66
S. Hamed, B. Brenner, A. Roguin. (2011) Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovascular Research 91:1, 9-15
CrossRef67
Katya B Rubinow, John K Amory, Stephanie T Page. (2011) Androgens exert sexually dimorphic effects on angiogenesis: novel insight into the relationship between androgens and cardiovascular disease. Asian Journal of Andrology 13:4, 626-627
CrossRef68
Giulia Paviotti, Gian Paolo Fadini, Elisa Boscaro, Carlo Agostini, Angelo Avogaro, Lino Chiandetti, Eugenio Baraldi, Marco Filippone. (2011) Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth. Early Human Development 87:7, 461-465
CrossRef69
Elisa Cangiano, Caterina Cavazza, Gianluca Campo, Marco Valgimigli, Gloria Francolini, Patrizia Malagutti, Claudio Pratola, Roberto Ferrari. (2011) Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. Journal of Thrombosis and Thrombolysis 32:1, 1-8
CrossRef70
Tobias Geisler, Lisa Fekecs, Thomas Wurster, Amedeo Chiribiri, Andreas Schuster, Eike Nagel, Stephan Miller, Meinrad Gawaz, Konstantinos Stellos, Boris Bigalke. (2011) Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI. European Journal of Radiology
CrossRef71
Lu-Lu Chen, Fan Yu, Tian-shu Zeng, Yun-fei Liao, Yu-ming Li, Hong-cheng Ding. (2011) Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. European Journal of Pharmacology 659:2-3, 296-301
CrossRef72
Akihiko TAGUCHI. (2011) Cell-based therapy for patients with vascular dementia. Psychogeriatrics 11:2, 113-115
CrossRef73
Ibiayi Dagogo-Jack, Samuel Dagogo-Jack. (2011) Dissociation Between Cardiovascular Risk Markers and Clinical Outcomes in African Americans: Need for Greater Mechanistic Insight. Current Cardiovascular Risk Reports 5:3, 200-206
CrossRef74
Jaemin Shim, Jae Hyung Park, Jong Youn Kim, Sook Kyoung Kim, Boyoung Joung, Moon-Hyoung Lee, Young-Hoon Kim, Hui-Nam Pak. (2011) Impaired mobilization of bone marrow derived CD34 positive mononuclear cells is related to the recurrence of atrial fibrillation after radiofrequency catheter ablation. International Journal of Cardiology
CrossRef75
Jacob N. Ablin, Viktoria Boguslavski, Valerie Aloush, Ori Elkayam, Daphna Paran, David Levartovski, Dan Caspi, Jacob George. (2011) Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. Rheumatology International 31:6, 773-778
CrossRef76
Dennis Ladage, Nora Schützeberg, Theresa Dartsch, Benjamin Krausgrill, Marcel Halbach, Carsten Zobel, Jochen Müller-Ehmsen. (2011) Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats. International Journal of Cardiology 149:2, 152-156
CrossRef77
Mayr Matthias, Niederseer David, Niebauer Josef. (2011) From Bench to Bedside: What Physicians Need to Know About Endothelial Progenitor Cells. The American Journal of Medicine 124:6, 489-497
CrossRef78
T. Thum, K. Schmitter, F. Fleissner, V. Wiebking, B. Dietrich, J. D. Widder, V. Jazbutyte, S. Hahner, G. Ertl, J. Bauersachs. (2011) Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. European Heart Journal 32:10, 1275-1286
CrossRef79
TORU TAKAHASHI, SATOSHI SUZUKI, HIROSHI KUBO, MUTSUO YAMAYA, SHIN KUROSAWA, MASATO KATO. (2011) Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease. Respirology 16:4, 680-687
CrossRef80
Alan W. Stitt, Christina L. O’Neill, Michelle T. O’Doherty, Desmond B. Archer, Tom A. Gardiner, Reinhold J. Medina. (2011) Vascular stem cells and ischaemic retinopathies. Progress in Retinal and Eye Research 30:3, 149-166
CrossRef81
K. Esposito, M. I. Maiorino, C. Di Palo, M. Gicchino, M. Petrizzo, G. Bellastella, F. Saccomanno, D. Giugliano. (2011) Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes-a randomized controlled trial. Diabetes, Obesity and Metabolism 13:5, 439-445
CrossRef82
Yvonne Clever, Bodo Cremers, Bastian Krauß, Michael Böhm, Ulrich Speck, Ulrich Laufs, Bruno Scheller. (2011) Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. EuroIntervention 7:K, K32-K42
CrossRef83
Elena Conti, Maria Beatrice Musumeci, Marco De Giusti, Eleonora Dito, Vittoria Mastromarino, Camillo Autore, Massimo Volpe. (2011) IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clinical Science 120:9, 377-402
CrossRef84
Ming Guo Xu, Li Na Men, Ying Zu, Chun Yu Zhao, Xiang Chun Meng, Tao Wang. (2011) The Functions of Endothelial Progenitor Cells Were Significantly Improved After Treatment With Intravenous Immunoglobulin and Aspirin in Children With Kawasaki Disease. Pediatric Cardiology 32:4, 455-460
CrossRef85
C. Klopsch, P. Donndorf, A. Kaminski, N. Ma, G. Steinhoff. (2011) Zellquellen für kardiovaskuläres Tissue Engineering. Der Chirurg 82:4, 295-302
CrossRef86
Jan Ramshorst, Sander F. Rodrigo, Martin J. Schalij, Saskia L. M. A. Beeres, Jeroen J. Bax, Douwe E. Atsma. (2011) Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future. Journal of Cardiovascular Translational Research 4:2, 182-191
CrossRef87
Anton JM Roks, Kathy Rodgers, Thomas Walther. (2011) Effects of the renin angiotensin system on vasculogenesis-related progenitor cells. Current Opinion in Pharmacology 11:2, 162-174
CrossRef88
Alexandros Briasoulis, Dimitris Tousoulis, Charalambos Antoniades, Nikos Papageorgiou, Christodoulos Stefanadis. (2011) The Role of Endothelial Progenitor Cells in Vascular Repair after Arterial Injury and Atherosclerotic Plaque Development. Cardiovascular Therapeutics 29:2, 125-139
CrossRef89
K. Y.-Y. Chan, P. Xiang, L. Zhou, K. Li, P.-C. Ng, C.-C. Wang, L. Zhang, H.-Y. Deng, N.-H. Pong, H. Zhao, W.-Y. Chan, R. Y.-T. Sung. (2011) Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks. European Journal of Heart Failure 13:4, 366-376
CrossRef90
Nicola Quaranta, Alfonso Ramunni, Concetta De Luca, Paola Brescia, Porzia Dambra, Giacomina De Tullio, Angelo Vacca, Antonio Quaranta. (2011) Endothelial progenitor cells in sudden sensorineural hearing loss. Acta Oto-laryngologica 131:4, 347-350
CrossRef91
Peter J. Psaltis, Adriana Harbuzariu, Sinny Delacroix, Eric W. Holroyd, Robert D. Simari. (2011) Resident Vascular Progenitor Cells—Diverse Origins, Phenotype, and Function. Journal of Cardiovascular Translational Research 4:2, 161-176
CrossRef92
Carolina de Ciuceis, Annamaria Pilu, Damiano Rizzoni, Enzo Porteri, Maria Lorenza Muiesan, Massimo Salvetti, Anna Paini, Eugenia Belotti, Francesca Zani, Gianluca E. M. Boari, Claudia Agabiti Rosei, Enrico Agabiti Rosei. (2011) Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension. Blood Pressure 20:2, 77-83
CrossRef93
Alberto Zambelli, Matteo Giovanni Della Porta, Ermanno Eleuteri, Luciana De Giuli, Oronzo Catalano, Carlo Tondini, Alberto Riccardi. (2011) Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. The Breast 20:2, 176-183
CrossRef94
M. Albiero, L. Menegazzo, E. Boscaro, C. Agostini, A. Avogaro, G. P. Fadini. (2011) Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia 54:4, 945-953
CrossRef95
Seungchul Yoo, Sil Kim, Seungmin Yoo, In-Taek Hwang, Haewol Cho, Myung-Shin Lee. (2011) Kaposi’s sarcoma-associated herpesvirus infection of endothelial progenitor cells impairs angiogenic activity in vitro. The Journal of Microbiology 49:2, 299-304
CrossRef96
G Rath, R Tripathi. (2011) VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario. Journal of Human Hypertension
CrossRef97
Masato Oda, Ken Toba, Kiminori Kato, Takuya Ozawa, Takao Yanagawa, Noboru Ikarashi, Tsugumi Takayama, Tomoyasu Suzuki, Haruo Hanawa, Masayoshi Masuko, Hironori Kobayashi, Yoshifusa Aizawa. (2011) Hypocellularity and insufficient expression of angiogenic factors in implanted autologous bone marrow in patients with chronic critical limb ischemia. Heart and Vessels
CrossRef98
Akihiko Taguchi, Pengxiang Zhu, Fang Cao, Akie Kikuchi-Taura, Yukiko Kasahara, David M Stern, Toshihiro Soma, Tomohiro Matsuyama, Ryuji Hata. (2011) Reduced ischemic brain injury by partial rejuvenation of bone marrow cells in aged rats. Journal of Cerebral Blood Flow & Metabolism 31:3, 855-867
CrossRef99
Izabela Tuleta, Stefan Pabst, Uwe R. Juergens, Georg Nickenig, Dirk Skowasch. (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis – implication for preventive and personalised treatment. The EPMA Journal 2:1, 39-47
CrossRef100
Monica Colvin-Adams, Adheesh Agnihotri. (2011) Cardiac allograft vasculopathy: current knowledge and future direction. Clinical Transplantation 25:2, 175-184
CrossRef101
Chen-Fuh Lam, Jun-Neng Roan, Chou-Hwei Lee, Pei-Jung Chang, Chein-Chi Huang, Yen-Chin Liu, Meei-Jyh Jiang, Yu-Chuan Tsai. (2011) Transplantation of Endothelial Progenitor Cells Improves Pulmonary Endothelial Function and Gas Exchange in Rabbits with Endotoxin-Induced Acute Lung Injury. Anesthesia & Analgesia 112:3, 620-627
CrossRef102
Ulrich Marc Becher, Vedat Tiyerili, Dirk Skowasch, Georg Nickenig, Nikos Werner. (2011) Personalized cardiac regeneration by stem cells–Hype or hope?. The EPMA Journal 2:1, 119-130
CrossRef103
Francesco Tecilazich, Thanh Dinh, Aristidis Veves. (2011) Treating diabetic ulcers. Expert Opinion on Pharmacotherapy 12:4, 593-606
CrossRef104
Rosalinda Madonna, Francesca V. Renna, Carlo Cellini, Roberto Cotellese, Nicola Picardi, Franco Francomano, Paolo Innocenti, Raffaele De Caterina. (2011) Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. European Journal of Clinical Investigation 41:2, 126-133
CrossRef105
Matthew R. Richardson, Mervin C. Yoder. (2011) Endothelial progenitor cells: Quo Vadis?. Journal of Molecular and Cellular Cardiology 50:2, 266-272
CrossRef106
Sigmund Silber, Peter Damman, Margo Klomp, Marcel Beijk, Manfred Grisold, Expedito Ribeiro, Harry Suryapranata, Jaroslaw Wójcik, Kui Hian Sim, Jan Tijssen, Robbert de Winter. (2011) Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 6:7, 819-825
CrossRef107
Ulrich M. Becher, Cathleen Endtmann, Vedat Tiyerili, Georg Nickenig, Nikos Werner. (2011) Endothelial Damage and Regeneration: The Role of the Renin-Angiotensin-Aldosterone System. Current Hypertension Reports 13:1, 86-92
CrossRef108
Joshua F. Baker, Lifeng Zhang, Sotonye Imadojemu, Alexis Sharpe, Sarita Patil, Jonni S. Moore, Emile R. Mohler, Joan Feldt. (2011) Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification. Rheumatology International
CrossRef109
O J MacEneaney, C A DeSouza, B R Weil, E J Kushner, G P Van Guilder, M L Mestek, J J Greiner, B L Stauffer. (2011) Prehypertension and endothelial progenitor cell function. Journal of Human Hypertension 25:1, 57-62
CrossRef110
Gene-Siew Ngian, Joanne Sahhar, Ian P Wicks, Sharon Van Doornum. (2011) Cardiovascular disease in systemic sclerosis - an emerging association?. Arthritis Research & Therapy 13:4, 237
CrossRef111
Robert A. Taylor, Adnan I. Qureshi. (2011) Therapeutic Role of Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia. Journal of Neuroimagingno-no
CrossRef112
Carl A. Hubel, Peter I. Sipos, Ian P. Crocker. (2011) Endothelial progenitor cells: Their potential role in pregnancy and preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:1, 48-58
CrossRef113
Dimitris Tousoulis, Ioannis Andreou, Marinos Tsiatas, Antigoni Miliou, Costas Tentolouris, Gerasimos Siasos, Nikos Papageorgiou, Christos A. Papadimitriou, Meletios-Athanasios Dimopoulos, Christodoulos Stefanadis. (2011) Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: The impact of inflammatory process and oxidative stress. Atherosclerosis 214:1, 151-157
CrossRef114
R. Goekmen Turan, C. Hakan Turan, Ilkay Bozdag-Turan, Jasmin Ortak, Ibrahim Akin, Stephan Kische, Henrik Schneider, Tilo Kleinfeldt, Tim C. Rehders, Mathias Rauchhaus, Esther Adolph, Shwan Amen, Tina Hermann, Sedat Yokus, Micheal Brehm, Stephan Steiner, Kurtulus Sahin, Christoph A. Nienaber, Hueseyin Ince. (2011) Impaired Mobilization of CD133+ Bone Marrow-Derived Circulating Progenitor Cells With an Increased Number of Diseased Coronary Arteries in Ischemic Heart Disease Patients With Diabetes. Circulation Journal 75:11, 2635-2641
CrossRef115
Maurizio Pesce, Ilaria Burba, Elisa Gambini, Francesca Prandi, Giulio Pompilio, Maurizio C. Capogrossi. (2011) Endothelial and cardiac progenitors: Boosting, conditioning and (re)programming for cardiovascular repair. Pharmacology & Therapeutics 129:1, 50-61
CrossRef116
Giuseppe Cianciolo, Gaetano La Manna, Maria L. Cappuccilli, Nicole Lanci, Elena Della Bella, Vania Cuna, Ada Dormi, Paola Todeschini, Gabriele Donati, Francesco Alviano, Roberta Costa, Gian Paolo Bagnara, Sergio Stefoni. (2011) VDR Expression on Circulating Endothelial Progenitor Cells in Dialysis Patients Is Modulated by 25(OH)D Serum Levels and Calcitriol Therapy. Blood Purification 32:3, 161-173
CrossRef117
Yi Yu, Yan Wang, Li-na Zhou, Feng Zheng. (2011) ARB Treatment Prevents the Decrease in Endothelial Progenitor Cells and the Loss of Renal Microvasculature in Remnant Kidney. American Journal of Nephrology 33:6, 550-557
CrossRef118
Hiroki Ueno, Hidenori Koyama, Yohei Mima, Shinya Fukumoto, Shinji Tanaka, Takuhito Shoji, Masanori Emoto, Tetsuo Shoji, Yoshiki Nishizawa, Masaaki Inaba. (2011) Comparison of the Effect of Cilostazol with Aspirin on Circulating Endothelial Progenitor Cells and Small-Dense LDL Cholesterol in Diabetic Patients with Cerebral Ischemia: A Randomized Controlled Pilot Trial. Journal of Atherosclerosis and Thrombosis 18:10, 883-890
CrossRef119
V. K. Shah, K. K. Shalia. (2011) Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells International 2011, 1-20
CrossRef120
Yasuyuki Fujita, Takayuki Asahara. (2011) Evaluation of Circulating Endothelial Progenitor Cells in Cardiovascular Risk. Circulation Journal 75:11, 2541-2542
CrossRef121
Yoshio Katsuki, Ken-ichiro Sasaki, Yasuyuki Toyama, Masanori Ohtsuka, Hiroshi Koiwaya, Takaharu Nakayoshi, Tsutomu Imaizumi. (2011) Early outgrowth EPCs generation is reduced in patients with Buerger’s disease. Clinical Research in Cardiology 100:1, 21-27
CrossRef122
S. Ylä-Herttuala, J. F. Bentzon, M. Daemen, E. Falk, H. M. Garcia-Garcia, J. Herrmann, I. Hoefer, J. W. Jukema, R. Krams, B. R. Kwak, N. Marx, M. Naruszewicz, A. Newby, G. Pasterkamp, P. W. J. C. Serruys, J. Waltenberger, C. Weber, L. Tokgözoglu. (2011) Stabilisation of atherosclerotic plaques. Thrombosis and Haemostasis 106:1, 1-19
CrossRef123
Z. Maniou, W. L. Hall, R. Gray, F. Lewis, P. T. Seed, P. J. Chowienczyk, T. A. B. Sanders. (2011) Effect of increasing doses of long chain n−3 PUFA on circulating endothelial progenitor cells in the MARINA study: a randomised controlled trial. Proceedings of the Nutrition Society 70:OCE4,
CrossRef124
Steven G. DuBois, Diana Stempak, Bing Wu, Reza Bayat Mokhtari, Rakesh Nayar, Katherine A. Janeway, Robert Goldsby, Holcombe E. Grier, Sylvain Baruchel. (2011) Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma. Pediatric Blood & Cancern/a-n/a
CrossRef125
Ilkay Bozdag-Turan, R.Goekmen Turan, C.Hakan Turan, Sophie Ludovicy, Ibrahim Akin, Stephan Kische, Nicole S. Arsoy, Henrik Schneider, Jasmin Ortak, Tim Rehders, Tina Hermann, Liliya Paranskaya, Peter Kohlschein, Manuela Bastian, A.Tulga Ulus, Kurtulus Sahin, Hueseyin Ince, Christoph A. Nienaber. (2011) Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Cardiovascular Diabetology 10:1, 107
CrossRef126
Abraham Aviv. 2011. Leukocyte Telomere Dynamics, Human Aging, and Life Span. , 163-176.
CrossRef127
Maarten B. Rookmaaker, Jaap A. Joles, Marianne C. Verhaar. 2011. Clinical Trials in Renal Regenerative Medicine. , 341-360.
CrossRef128
Michael S. Goligorsky. 2011. Stem Cell Injury and Premature Senescence. , 275-288.
CrossRef129
Gordon L. Chen, Chunming Dong, Pascal J. Goldschmidt-Clermont. (2010) Journey in Antithrombotic Strategies for ST-Elevation Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 9:4, 235-242
CrossRef130
L. Chen, F. Wu, W.-h. Xia, Y.-y. Zhang, S.-y. Xu, F. Cheng, X. Liu, X.-y. Zhang, S.-m. Wang, J. Tao. (2010) CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells. Cardiovascular Research 88:3, 462-470
CrossRef131
Eric N. Liberda, Azita K. Cuevas, Patricia A. Gillespie, Gabriele Grunig, Qingshan Qu, Lung Chi Chen. (2010) Exposure to inhaled nickel nanoparticles causes a reduction in number and function of bone marrow endothelial progenitor cells. Inhalation Toxicology 22:S2, 95-99
CrossRef132
M. Gossl, U. I. Modder, R. Gulati, C. S. Rihal, A. Prasad, D. Loeffler, L. O. Lerman, S. Khosla, A. Lerman. (2010) Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. European Heart Journal 31:23, 2909-2914
CrossRef133
D. H. Krieter, R. Fischer, K. Merget, H.-D. Lemke, A. Morgenroth, B. Canaud, C. Wanner. (2010) Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy. Nephrology Dialysis Transplantation 25:12, 4023-4031
CrossRef134
Janine Pöss, Christian Werner, Dominik Lorenz, Christoph Gensch, Michael Böhm, Ulrich Laufs. (2010) The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice. Basic Research in Cardiology 105:6, 725-735
CrossRef135
S J Hoesli, L E Mead, D Prater, M J Javed, D A Ingram, S C Denne. (2010) Endothelial colony-forming cells and mesenchymal stem cells from ECMO circuits of term infants. Journal of Perinatology 30:11, 724-730
CrossRef136
C. Heiss, C. L. Keen, M. Kelm. (2010) Flavanols and cardiovascular disease prevention. European Heart Journal 31:21, 2583-2592
CrossRef137
Dirk Henrich, Caroline Seebach, Eva Sterlepper, Christian Tauchmann, Ingo Marzi, Johannes Frank. (2010) RIA reamings and hip aspirate: A comparative evaluation of osteoprogenitor and endothelial progenitor cells. Injury 41, S62-S68
CrossRef138
S. Zimmer, G. Nickenig. (2010) Prediction and prevention by progenitors? Stent thrombosis and EPCs. European Heart Journal 31:21, 2569-2571
CrossRef139
H. DeLisser, Y. Liu, P.-Y. Desprez, A. Thor, P. Briasouli, C. Handumrongkul, J. Wilfong, G. Yount, M. Nosrati, S. Fong, E. Shtivelman, M. Fehrenbach, G. Cao, D. H. Moore, S. Nayak, D. Liggitt, M. Kashani-Sabet, R. Debs. (2010) Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proceedings of the National Academy of Sciences 107:43, 18616-18621
CrossRef140
Daniel J. Penny, Giles Wesley Vick. (2010) Novel Therapies in Childhood Heart Failure: Today and Tomorrow. Heart Failure Clinics 6:4, 591-621
CrossRef141
Peng Gao, Yongmei Chen, Michael T Lawton, Nicholas M Barbaro, Guo-Yuan Yang, Hua Su, Feng Ling, William L Young. (2010) Evidence of Endothelial Progenitor Cells in the Human Brain and Spinal Cord Arteriovenous Malformations. Neurosurgery 67:4, 1029-1035
CrossRef142
Lu-lu Chen, Yun-fei Liao, Tian-shu Zeng, Fan Yu, Hui-qing Li, Yong Feng. (2010) Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine 38:2, 266-275
CrossRef143
Hsueh-Wen Chang, Steve Leu, Cheuk-Kwan Sun, Chi-Ling Hang, Ali A. Youssef, Yuan-Kai Hsieh, Cheng-Hsu Yang, Cheng-I. Cheng, Shyh-Ming Chen, Chien-Jen Chen, Sarah Chua, Li-Teh Chang, Chiung-Jen Wu, Hon-Kan Yip. (2010) Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies. Translational Research 156:4, 251-263
CrossRef144
Lorenzo A Calò, Paul A Davis. (2010) Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartterʼs and Gitelmanʼs syndromes patients. Journal of Hypertension 28:10, 2169-2170
CrossRef145
Cornelius F.H. Mueller, Shazia Afzal, Ulrich Marc Becher, Sven Wassmann, Georg Nickenig, Kerstin Wassmann. (2010) Role of the multidrug resistance protein-1 (MRP1) for endothelial progenitor cell function and survival. Journal of Molecular and Cellular Cardiology 49:3, 482-489
CrossRef146
Naohiko Kobayashi, Hiromichi Fukushima, Hiroshi Takeshima, Wataru Koguchi, Yasuko Mamada, Hisato Hirata, Yoshifumi Machida, Noriko Suzuki, Fumie Yokotsuka, Kyoko Tabei, Eri Kobayashi, Noboru Fukuda, Toshihiko Ishimitsu. (2010) Effect of Eplerenone on Endothelial Progenitor Cells and Oxidative Stress in Ischemic Hindlimb. American Journal of Hypertension 23:9, 1007-1013
CrossRef147
David J. Margolis, Ole Hoffstad, Stephen Thom, Warren Bilker, Arturo R. Maldonado, Robert M. Cohen, Bruce J. Aronow, Timothy Crombleholme. (2010) The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes. Wound Repair and Regeneration 18:5, 445-451
CrossRef148
Victor W. Wong, Kristine C. Rustad, Michael T. Longaker, Geoffrey C. Gurtner. (2010) Tissue Engineering in Plastic Surgery: A Review. Plastic and Reconstructive Surgery 126:3, 858-868
CrossRef149
Owen J. MacEneaney, Erich J. Kushner, Christian M. Westby, Jennifer N. Cech, Jared J. Greiner, Brian L. Stauffer, Christopher A. DeSouza. (2010) Endothelial Progenitor Cell Function, Apoptosis, and Telomere Length in Overweight/Obese Humans. Obesity 18:9, 1677-1682
CrossRef150
Elena Bartoloni, Alessia Alunno, Filippo Luccioli, Sheila Moscatelli, Devid Biscontini, Gianluca Santoboni, Roberto Gerli. (2010) Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link. Expert Review of Cardiovascular Therapy 8:9, 1309-1316
CrossRef151
Rui Andre Providencia. (2010) Headache and cardiovascular disease: old symptoms, new proposals. Future Cardiology 6:5, 703-723
CrossRef152
Liza S. M. Wong, Pim Harst, Rudolf A. Boer, Jardi Huzen, Wiek H. Gilst, Dirk J. Veldhuisen. (2010) Aging, telomeres and heart failure. Heart Failure Reviews 15:5, 479-486
CrossRef153
Mohamad Amer Alaiti, Masakazu Ishikawa, Marco A. Costa. (2010) Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy. Translational Research 156:3, 112-129
CrossRef154
Christiane Arnold, Daniel Wenta, Jochen Müller-Ehmsen, Narayanswami Sreeram, Christine Graf. (2010) Progenitor cell number is correlated to physical performance in obese children and young adolescents. Cardiology in the Young 20:04, 381-386
CrossRef155
A. Surdacki, E. Marewicz, E. Wieczorek-Surdacka, T. Rakowski, G. Szastak, J. Pryjma, D. Dudek, J. S. Dubiel. (2010) Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Nephrology Dialysis Transplantation 25:8, 2576-2583
CrossRef156
Ki E Park, Carl J Pepine. (2010) Bone marrow-derived cells and hypertension. Expert Review of Cardiovascular Therapy 8:8, 1139-1148
CrossRef157
Po-Hsun Huang, Shao-Sung Huang, Yung-Hsiang Chen, Chih-Pei Lin, Kuang-Hsing Chiang, Jia-Shiong Chen, Hsiao-Ya Tsai, Feng-Yen Lin, Jaw-Wen Chen, Shing-Jong Lin. (2010) Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. Journal of Hypertension 28:8, 1655-1665
CrossRef158
Ernest Sala, Cristina Villena, Catalina Balaguer, Angel Ríos, Carlos Fernández-Palomeque, Borja G. Cosío, Javier García, Aina Noguera, Alvar Agustí. (2010) Abnormal Levels of Circulating Endothelial Progenitor Cells During Exacerbations of COPD. Lung 188:4, 331-338
CrossRef159
M.U. Becher, G. Nickenig, N. Werner. (2010) Regeneration of the vascular compartment. Herz 35:5, 342-351
CrossRef160
Elena Bartoloni, Alessia Alunno, Onelia Bistoni, Roberto Gerli. (2010) How early is the atherosclerotic risk in rheumatoid arthritis?. Autoimmunity Reviews 9:10, 701-707
CrossRef161
Cinzia Zuchi, Giuseppe Ambrosio, Thomas F. Lüscher, Ulf Landmesser. (2010) Nutraceuticals in Cardiovascular Prevention: Lessons from Studies on Endothelial Function. Cardiovascular Therapeutics 28:4, 187-201
CrossRef162
Riccardo Candido, Mark E. Cooper, Karin A. M. Jandeleit-Dahm. 2010. The Pathogenesis of Macrovascular Complications Including Atherosclerosis in Diabetes. , 635-656.
CrossRef163
G. P. Fadini, A. Avogaro. (2010) Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes, Obesity and Metabolism 12:7, 570-583
CrossRef164
Christian Heiss, Sarah Jahn, Melanie Taylor, Wendy May Real, Franca S. Angeli, Maelene L. Wong, Nicolas Amabile, Megha Prasad, Tienush Rassaf, Javier I. Ottaviani, Shirley Mihardja, Carl L. Keen, Matthew L. Springer, Andrew Boyle, William Grossman, Stanton A. Glantz, Hagen Schroeter, Yerem Yeghiazarians. (2010) Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 56:3, 218-224
CrossRef165
Caroline Schmidt-Lucke, Stephan Fichtlscherer, Lothar Rössig, Ulrike Kämper, Stefanie Dimmeler. (2010) Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 211:1, 249-254
CrossRef166
I. Jialal, S. Devaraj, U. Singh, B.A. Huet. (2010) Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk. Atherosclerosis 211:1, 297-302
CrossRef167
Harald F. Langer, Jürgen W. Ruhr, Karin Daub, Tanja Schoenberger, Konstantinos Stellos, Andreas E. May, Hannah Schnell, Alexandra Gauß, Ramona Hafner, Peter Lang, Michael Schumm, Hans-Jörg Bühring, Karin Klingel, Sabine Conrad, Martin Schaller, Marc Zandvoort, Gundram Jung, Stefanie Dimmeler, Thomas Skutella, Meinrad Gawaz. (2010) Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. Journal of Molecular Medicine 88:7, 687-699
CrossRef168
Ya-li HUANG, Yan WANG, Tong LU. (2010) Endothelial progenitor cells: functions and clinical application in cardiac and vascular diseases. Academic Journal of Second Military Medical University 30:5, 545-548
CrossRef169
A. Di Mambro, A. Ferlin, L. De Toni, R. Selice, N. Caretta, C. Foresta. (2010) Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome. Molecular Human Reproduction 16:6, 411-417
CrossRef170
Chethan J. Sathya, Rohit Sheshgiri, Jessica Prodger, Laura Tumiati, Diego Delgado, Heather J. Ross, Vivek Rao. (2010) Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transplant International 23:6, 641-648
CrossRef171
Martin Steinmetz, Caroline Brouwers, Georg Nickenig, Sven Wassmann. (2010) Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells. Journal of Cellular and Molecular Medicine 14:6b, 1645-1656
CrossRef172
István Kiss, Antal Tibold, Róbert Halmosi, Éva Bartha, Katalin Koltai, Zsuzsanna Orsós, László Bujdosó, István Ember. (2010) Enhancement of Organ Regeneration in Animal Models by a Stem Cell-Stimulating Plant Mixture. Journal of Medicinal Food 13:3, 599-604
CrossRef173
Ishwarlal Jialal. (2010) Endothelial Progenitor Cell Status in Metabolic Syndrome. Metabolic Syndrome and Related Disorders 8:3, 193-195
CrossRef174
XueJun Yu, MingBao Song, JianFei Chen, GuangXu Zhu, Gang Zhao, Hong Wang, Lan Hunag. (2010) Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. Molecular Biology Reports 37:5, 2423-2429
CrossRef175
Yury G. Kaminsky, Elena A. Kosenko. (2010) Molecular mechanisms of toxicity of simvastatin, widely used cholesterol-lowering drug. A review. Central European Journal of Medicine 5:3, 269-279
CrossRef176
K. E. Jie, M. A. Zaikova, M. W. T. Bergevoet, P. E. Westerweel, M. Rastmanesh, P. J. Blankestijn, W. H. Boer, B. Braam, M. C. Verhaar. (2010) Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrology Dialysis Transplantation 25:6, 1875-1882
CrossRef177
Wiktor Kuliczkowski, Roksolana Derzhko, Iwona Prajs, Maria Podolak-Dawidziak, Victor L Serebruany. (2010) Endothelial Progenitor Cells and Left Ventricle Function in Patients With Acute Myocardial Infarction: Potential Therapeutic Considertions. American Journal of Therapeutics1
CrossRef178
M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, R. J. de Winter. (2010) GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. European Heart Journal 31:9, 1055-1064
CrossRef179
John Paul Kirton, Qingbo Xu. (2010) Endothelial precursors in vascular repair. Microvascular Research 79:3, 193-199
CrossRef180
Patrick WF Hadoke. (2010) Is endothelial progenitor cell senescence a therapeutic target in hypertension?. Journal of Hypertension 28:5, 887-888
CrossRef181
Emeline M. Van Craenenbroeck, Viviane M. Conraads. (2010) Endothelial progenitor cells in vascular health: Focus on lifestyle. Microvascular Research 79:3, 184-192
CrossRef182
Shin-Chen Pan, Li-Wha Wu, Chung-Lin Chen, Shyh-Jou Shieh, Haw-Yen Chiu. (2010) Deep partial thickness burn blister fluid promotes neovascularization in the early stage of burn wound healing. Wound Repair and Regeneration 18:3, 311-318
CrossRef183
Florian H. Seeger, Daniel Sedding, Alexander C. Langheinrich, Judith Haendeler, Andreas M. Zeiher, Stefanie Dimmeler. (2010) Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression. Basic Research in Cardiology 105:3, 389-397
CrossRef184
R. J. Jaumdally, P. K. Y. Goon, C. Varma, A. D. Blann, G. Y. H. Lip. (2010) Effects of atorvastatin on circulating CD34+/CD133+/ CD45− progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. Journal of Internal Medicine 267:4, 385-393
CrossRef185
Yusuke Higashi, Sergiy Sukhanov, Asif Anwar, Shaw-Yung Shai, Patrice Delafontaine. (2010) IGF-1, oxidative stress and atheroprotection. Trends in Endocrinology & Metabolism 21:4, 245-254
CrossRef186
Kaoru Yasuda, Hyeong-Cheon Park, Brian Ratliff, Francesco Addabbo, Antonis K. Hatzopoulos, Praveen Chander, Michael S. Goligorsky. (2010) Adriamycin Nephropathy. The American Journal of Pathology 176:4, 1685-1695
CrossRef187
Sven Möbius-Winkler, Axel Linke, Volker Adams, Gerhard Schuler, Sandra Erbs. (2010) How to improve endothelial repair mechanisms: the lifestyle approach. Expert Review of Cardiovascular Therapy 8:4, 573-580
CrossRef188
Yongfeng Fan, Fanxia Shen, Tim Frenzel, Wei Zhu, Jianqin Ye, Jianrong Liu, Yongmei Chen, Hua Su, William L. Young, Guo-Yuan Yang. (2010) Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Annals of Neurology 67:4, 488-497
CrossRef189
Kai C. Wollert, Helmut Drexler. (2010) Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nature Reviews Cardiology 7:4, 204-215
CrossRef190
Bethan Freestone, Suresh Krishnamoorthy, Gregory YH Lip. (2010) Assessment of endothelial dysfunction. Expert Review of Cardiovascular Therapy 8:4, 557-571
CrossRef191
Gareth J. Padfield, David E. Newby, Nicholas L. Mills. (2010) Understanding the Role of Endothelial Progenitor Cells in Percutaneous Coronary Intervention. Journal of the American College of Cardiology 55:15, 1553-1565
CrossRef192
Jeremy L. Herrmann, Aaron M. Abarbanell, Brent R. Weil, Mariuxi C. Manukyan, Jeffrey A. Poynter, Yue Wang, Arthur C. Coffey, Daniel R. Meldrum. (2010) Gender Dimorphisms in Progenitor and Stem Cell Function in Cardiovascular Disease. Journal of Cardiovascular Translational Research 3:2, 103-113
CrossRef193
Curtis L. Cetrulo, Margaret J. Starnes. 2010. Perinatal Endothelial Progenitor Cells. , 95-102.
CrossRef194
Qiong WU, Jia-Fei XI, Ya-Li LI, Xue-Tao PEI. (2010) Progress of Differentiating Human Embryonic Stem Cells Into Endothelial Progenitor Cells and Potential Applications*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 37:2, 138-144
CrossRef195
Joy A. Cavagnaro. 2010. Considerations in Design of Preclinical Safety Evaluation Programs to Support Human Cell-Based Therapies. .
CrossRef196
Worku Abebe, Mahmood Mozaffari. (2010) Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools. The EPMA Journal 1:1, 32-45
CrossRef197
Mahalia S. Desruisseaux, Fabiana S. Machado, Louis M. Weiss, Herbert B. Tanowitz, Linnie M. Golightly. (2010) Cerebral Malaria. The American Journal of Pathology 176:3, 1075-1078
CrossRef198
Alberto Zambelli, Matteo Della Porta, Vittorio Rosti. (2010) From cancer patients to cancer survivors: The issue of Cardioncology – A biological perspective. European Journal of Cancer 46:4, 697-702
CrossRef199
E. Kushner, G. Van Guilder, O. MacEneaney, J. Greiner, J. Cech, B. Stauffer, C. DeSouza. (2010) Ageing and endothelial progenitor cellrelease of proangiogenic cytokines. Age and Ageing 39:2, 268-272
CrossRef200
Natália António, Rosa Fernandes, Noela Rodriguez-Losada, Manuel F. Jiménez-Navarro, Artur Paiva, Eduardo Teresa Galván, Lino Gonçalves, Carlos Fontes Ribeiro, Luís A. Providência. (2010) Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs. European Journal of Clinical Pharmacology 66:3, 219-230
CrossRef201
Ming-Guo Xu, Li-Na Men, Chun-Yu Zhao, Xia Zhao, Yuan-Xiang Wang, Xiang-Chun Meng, Ding-Rong Shen, Bao-Ying Meng, Qing Zhang, Tao Wang. (2010) The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. European Journal of Pediatrics 169:3, 289-296
CrossRef202
Alexandra Rousseau, Fida Ayoubi, Christel Deveaux, Beny Charbit, Catherine Delmau, Sophie Christin-Maitre, Patrice Jaillon, Georges Uzan, Tabassome Simon. (2010) Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects. Fertility and Sterility 93:3, 843-846
CrossRef203
S. MARIUCCI, B. ROVATI, K. BENCARDINO, M. MANZONI, M. DANOVA. (2010) Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects. International Journal of Laboratory Hematology 32:1p1, e40-e48
CrossRef204
Carly Skamra, Rosalind Ramsey-Goldman. (2010) Management of cardiovascular complications in systemic lupus erythematosus. International Journal of Clinical Rheumatology 5:1, 75-100
CrossRef205
Gian Paolo Fadini, Claudio Pagano, Ilenia Baesso, Olympia Kotsafti, Daniele Doro, Saula V. de Kreutzenberg, Angelo Avogaro, Carlo Agostini, Maria T. Dorigo. (2010) Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma. Acta Ophthalmologica 88:1, 135-141
CrossRef206
H. Möllmann, H. Nef, C.W. Hamm. (2010) Stammzellen beim Myokardinfarkt. Der Kardiologe 4:1, 13-22
CrossRef207
H. Ueno, H. Koyama, S. Fukumoto, S. Tanaka, T. Shoji, T. Shoji, M. Emoto, H. Tahara, Y. Tsujimoto, T. Tabata, Y. Nishizawa. (2010) Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients. Nephrology Dialysis Transplantation 25:2, 581-586
CrossRef208
M. Toshner, N. W Morrell. (2010) Endothelial progenitor cells in pulmonary hypertension â dawn of cell-based therapy?. International Journal of Clinical Practice 64, 7-12
CrossRef209
Carlo Foresta, Luca De Toni, Alberto Ferlin, Antonella Di Mambro. (2010) Clinical implication of endothelial progenitor cells. Expert Review of Molecular Diagnostics 10:1, 89-105
CrossRef210
Chang-Ho Yun, Keun-Hwa Jung, Kon Chu, So-Hyun Kim, Ki-Hwan Ji, Hee-Kwon Park, Hwan-Cheol Kim, Soon-Tae Lee, Sang-Kun Lee, Jae-Kyu Roh. (2010) Increased Circulating Endothelial Microparticles and Carotid Atherosclerosis in Obstructive Sleep Apnea. Journal of Clinical Neurology 6:2, 89
CrossRef211
C. Shen, Q. Li, Y.C. Zhang, G. Ma, Y. Feng, Q. Zhu, Q. Dai, Z. Chen, Y. Yao, L. Chen, Y. Jiang, N. Liu. (2010) Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways. Biomedicine & Pharmacotherapy 64:1, 35-43
CrossRef212
Yasunobu Hirata, Daisuke Nagata, Etsu Suzuki, Hiroaki Nishimatsu, Jun-ichi Suzuki, Ryozo Nagai. (2010) Diagnosis and Treatment of Endothelial Dysfunction in Cardiovascular Disease. International Heart Journal 51:1, 1-6
CrossRef213
Yong Feng, Shu-Hua Yang, Bao-Jun Xiao, Wei-Hua Xu, Shu-Nan Ye, Tian Xia, Dong Zheng, Xian-Zhe Liu, Yun-Fei liao. (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46:1, 32-40
CrossRef214
Jeong Ae Park, Young-Guen Kwon. (2010) Could Circulating Progenitor Cell Count Be a Barometer for Coronary Artery Disease Progression?. Circulation Journal 74:9, 1804-1805
CrossRef215
P. Ebner, F. Picard, J. Richter, E. Darrelmann, M. Schneider, B.-E. Strauer, M. Brehm. (2010) Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. Rheumatology 49:1, 63-72
CrossRef216
Akio Kuroi, Toshio Imanishi, Hiroyuki Suzuki, Hideyuki Ikejima, Hiroto Tsujioka, Norishige Yoshikawa, Takashi Akasaka. (2010) Clinical Characteristics of Patients With Kawasaki Disease and Levels of Peripheral Endothelial Progenitor Cells and Blood Monocyte Subpopulations. Circulation Journal 74:12, 2720-2725
CrossRef217
Nana-Maria Heida, Jan-Peter Müller, I.-Fen Cheng, Maren Leifheit-Nestler, Vivien Faustin, Joachim Riggert, Gerd Hasenfuss, Stavros Konstantinides, Katrin Schäfer. (2010) Effects of Obesity and Weight Loss on the Functional Properties of Early Outgrowth Endothelial Progenitor Cells. Journal of the American College of Cardiology 55:4, 357-367
CrossRef218
Francesco Pelliccia, Cinzia Cianfrocca, Giuseppe Rosano, Giuseppe Mercuro, Giulio Speciale, Vincenzo Pasceri. (2010) Role of Endothelial Progenitor Cells in Restenosis and Progression of Coronary Atherosclerosis After Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 3:1, 78-86
CrossRef219
Robbert J. De Winter, Margo Klomp. (2010) Understanding the Role of Endothelial Progenitor Cells in Cardiovascular Disease, Coronary Artery Lesion Progression, and In-Stent Restenosis. JACC: Cardiovascular Interventions 3:1, 87-89
CrossRef220
Kenshiro Arao, Takanori Yasu, Nobuhiro Ohmura, Yoshiaki Tsukamoto, Miho Murata, Norifumi Kubo, Tomio Umemoto, Nahoko Ikeda, Junya Ako, San-e Ishikawa, Masanobu Kawakami, Shin-ichi Momomura. (2010) Circulating CD34+/133+ Progenitor Cells in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention. Circulation Journal 74:9, 1929-1935
CrossRef221
D. Skowasch, G. Bönner, G. Nickenig. (2009) Obstruktive Schlafapnoe als Risikofaktor der Arteriosklerose. Somnologie - Schlafforschung und Schlafmedizin 13:4, 215-220
CrossRef222
W. Sieghart, S. Fellner, T. Reiberger, G. Ulbrich, A. Ferlitsch, V. Wacheck, M. Peck-Radosavljevic. (2009) Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Digestive and Liver Disease 41:12, 902-906
CrossRef223
Sarah Witkowski, Michael M. Lockard, Nathan T. Jenkins, Thomas O. Obisesan, Espen E. Spangenburg, James M. Hagberg. (2009) Relationship between circulating progenitor cells, vascular function and oxidative stress with long-term training and short-term detraining in older men. Clinical Science 118:4, 303-311
CrossRef224
Valdo Jose Dias Silva, Marcus Paulo Ribeiro Machado, Julio Cesar Voltarelli. (2009) Current status of cell therapy for systemic arterial hypertension. Expert Review of Cardiovascular Therapy 7:11, 1307-1311
CrossRef225
Giuseppe Coppolino, Antoine Buemi, Davide Bolignano, Antonio Lacquaniti, Michele La Spada, Francesco Stilo, Giovanni De Caridi, Francesco Benedetto, Saverio Loddo, Michele Buemi, Francesco Spinelli. (2009) Perioperative Iloprost and Endothelial Progenitor Cells in Uremic Patients With Severe Limb Ischemia Undergoing Peripheral Revascularization. Journal of Surgical Research 157:1, e129-e135
CrossRef226
Giovanna Balconi, Ralf Lehmann, Fabio Fiordaliso, Birgit Assmus, Stefanie Dimmeler, Patrizio Sarto, Emanuele Carbonieri, Alessandra Gualco, Carlo Campana, Laura Angelici, Serge Masson, Salman Aa Mohammed, Elisabetta Dejana, Marco Gorini, Andreas M. Zeiher, Roberto Latini. (2009) Levels of Circulating Pro-angiogenic Cells Predict Cardiovascular Outcomes in Patients With Chronic Heart Failure. Journal of Cardiac Failure 15:9, 747-755
CrossRef227
Riccardo Candido, Stella Bernardi, Terri J Allen. (2009) Linking diabetes and atherosclerosis. Expert Review of Endocrinology & Metabolism 4:6, 603-624
CrossRef228
John D. Stroncek, Bryan S. Grant, Melissa A. Brown, Thomas J. Povsic, George A. Truskey, William M. Reichert. (2009) Comparison of Endothelial Cell Phenotypic Markers of Late-Outgrowth Endothelial Progenitor Cells Isolated from Patients with Coronary Artery Disease and Healthy Volunteers. Tissue Engineering Part A 15:11, 3473-3486
CrossRef229
Vasileios Petoumenos, Georg Nickenig, Nikos Werner. (2009) High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells. Journal of Cellular and Molecular Medicine 13:11-12, 4623-4635
CrossRef230
Gian Paolo Fadini, Saula de Kreutzenberg, Carlo Agostini, Elisa Boscaro, Antonio Tiengo, Stefanie Dimmeler, Angelo Avogaro. (2009) Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 207:1, 213-219
CrossRef231
Jula K. Inrig, Uptal D. Patel, Robert D. Toto, Lynda A. Szczech. (2009) Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wave 2 Study. American Journal of Kidney Diseases 54:5, 881-890
CrossRef232
J. Zavada, L. Kideryova, R. Pytlik, Z. Hruskova, V. Tesar. (2009) Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology 48:10, 1197-1201
CrossRef233
Lina Kang, Qin Chen, Lian Wang, Ling Gao, Kui Meng, Junhao Chen, Albert Ferro, Biao Xu. (2009) Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clinical and Experimental Pharmacology and Physiology 36:10, e47-e56
CrossRef234
Eliana Lucchinetti, Steffen M. Zeisberger, Isabella Baruscotti, Johannes Wacker, Jianhua Feng, Kathrin Zaugg, Raghvendra Dubey, Andreas H. Zisch, Michael Zaugg. (2009) Stem Cell-Like Human Endothelial Progenitors Show Enhanced Colony-Forming Capacity After Brief Sevoflurane Exposure: Preconditioning of Angiogenic Cells by Volatile Anesthetics. Anesthesia & Analgesia 109:4, 1117-1126
CrossRef235
Andrea Garolla, Renata D’Incà, Davide Checchin, Andrea Biagioli, Luca De Toni, Valentina Nicoletti, Marco Scarpa, Elisa Bolzonello, Giacomo Carlo Sturniolo, Carlo Foresta. (2009) Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis. The American Journal of Gastroenterology 104:10, 2500-2507
CrossRef236
Thomas J. Povsic, Stacie D. Adams, Katherine L. Zavodni, Francine Kelly, Laura G. Melton, Sunil V. Rao, Samer S. Najjar, Robert A. Harrington, Eric D. Peterson. (2009) Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples. Journal of Thrombosis and Thrombolysis 28:3, 259-265
CrossRef237
Ge Zhang, Hui Sheng, Yi-Xin He, Xin-Hui Xie, Yi-Xiang Wang, Kwong-Man Lee, Ka-Wai Yeung, Zi-Rong Li, Wei He, James F. Griffith, Kwok-Sui Leung, Ling Qin. (2009) Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions. Arthritis & Rheumatism 60:10, 2966-2977
CrossRef238
Doris A Taylor. (2009) From stem cells and cadaveric matrix to engineered organs. Current Opinion in Biotechnology 20:5, 598-605
CrossRef239
Lindsey Tilling, Philip Chowienczyk, Brian Clapp. (2009) Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. British Journal of Clinical Pharmacology 68:4, 484-492
CrossRef240
S. Y. Foo, E. R. Heller, J. Wykrzykowska, C. J. Sullivan, J. J. Manning-Tobin, K. J. Moore, R. E. Gerszten, A. Rosenzweig. (2009) Vascular effects of a low-carbohydrate high-protein diet. Proceedings of the National Academy of Sciences 106:36, 15418-15423
CrossRef241
Gian Paolo Fadini, Mattia Albiero, Andrea Cignarella, Chiara Bolego, Christian Pinna, Elisa Boscaro, Elisa Pagnin, Renzo De Toni, Saula De Kreutzenberg, Carlo Agostini, Angelo Avogaro. (2009) Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clinical Science 117:10, 355-364
CrossRef242
TJ Schwedt. (2009) Endothelial dysfunction in migraine. Cephalalgia 29:9, 997-1002
CrossRef243
Carlo Foresta, Antonella Di Mambro, Nicola Caretta, Luca De Toni, Daniela Zuccarello, Alberto Ferlin. (2009) Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment. Clinical Endocrinology 71:3, 412-416
CrossRef244
Doris A. Taylor, Matthew J. Robertson. (2009) Fundamentos de la terapia celular para el tratamiento de las enfermedades cardiovasculares: no hay una célula adecuada para todo. Revista Española de Cardiología 62:9, 1032-1044
CrossRef245
Erik B. Friedrich, Christian Werner, Katrin Walenta, Michael Böhm, Bruno Scheller. (2009) Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Research in Cardiology 104:5, 613-620
CrossRef246
N JOURDE-CHICHE, L DOU, F SABATIER, R CALAF, C. CERINI, S ROBERT, L CAMOIN-JAU, P CHARPIOT, A ARGILES, F DIGNAT-GEORGE, P BRUNET. (2009) Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. Journal of Thrombosis and Haemostasis 7:9, 1576-1584
CrossRef247
Rachel T. van Beem, Erfan Nur, Jaap Jan Zwaginga, Precious P. Landburg, Eduard J. van Beers, Ashley J. Duits, Dees P. Brandjes, Ingrid Lommerse, Hetty C. de Boer, C. Ellen van der Schoot, John-John B. Schnog, Bart J. Biemond. (2009) Elevated endothelial progenitor cells during painful sickle cell crisis. Experimental Hematology 37:9, 1054-1059
CrossRef248
Richard M. Cubbon, Matthew B. Kahn, Stephen B. Wheatcroft. (2009) Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clinical Science 117:5, 173-190
CrossRef249
Annette Schmidt, Birgit Bölck, Maria Jedig, Dirk Steinritz, Frank Balszuweit, Kai Kehe, Wilhelm Bloch. (2009) Nitrogen mustard (Chlorambucil) has a negative influence on early vascular development. Toxicology 263:1, 32-40
CrossRef250
S. K. Kim, H.-N. Pak, J. H. Park, J. I. Choi, M.-H. Nam, Y. Jo, Y.-H. Kim. (2009) Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1 mechanism. Europace 11:8, 1024-1031
CrossRef251
Li Lu, Jian-zhong Zhou, Li Wang, Tie-xu Zhang. (2009) Effects of Xuezhikang (
) and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension. Chinese Journal of Integrative Medicine 15:4, 266-271
CrossRef252
Mariana J. Kaplan. (2009) Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?. Translational Research 154:2, 61-69
CrossRef253
Caroline Lemieux, Isabelle Cloutier, Jean-François Tanguay. (2009) Menstrual cycle influences endothelial progenitor cell regulation: A link to gender differences in vascular protection?. International Journal of Cardiology 136:2, 200-210
CrossRef254
M. Hanefeld. (2009) The role of pioglitazone in modifying the atherogenic lipoprotein profile. Diabetes, Obesity and Metabolism 11:8, 742-756
CrossRef255
Francesco Pelliccia, Vincenzo Pasceri, Cinzia Cianfrocca, Cristiana Vitale, Christian Pristipino, Giulio Speciale, Giuseppe Mercuro, Giuseppe Rosano. (2009) Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction. Coronary Artery Disease 20:5, 303-308
CrossRef256
L. Sibal, A. Aldibbiat, S. C. Agarwal, G. Mitchell, C. Oates, S. Razvi, J. U. Weaver, J. A. Shaw, P. D. Home. (2009) Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 52:8, 1464-1473
CrossRef257
Ting-Hin Luk, Yuk-Ling Dai, Chung-Wah Siu, Kai-Hang Yiu, Hiu-Ting Chan, Daniel Yee-Tak Fong, Stephen W.L. Lee, Sheung-Wai Li, Sidney Tam, Chu-Pak Lau, Hung-Fat Tse. (2009) Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease. European Journal of Cardiovascular Prevention & Rehabilitation 16:4, 464-471
CrossRef258
Nobuhisa Nakamura, Keiko Naruse, Takashi Matsuki, Yoji Hamada, Eitaro Nakashima, Hideki Kamiya, Tatsuaki Matsubara, Atsushi Enomoto, Masahide Takahashi, Yutaka Oiso, Jiro Nakamura. (2009) Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1. FEBS Letters 583:15, 2457-2463
CrossRef259
Qiang Shi, Vida Hodara, Stephanie D. Butler, Charles A. Thomas III, Gene B. Hubbard, John L. VandeBerg, Xing L. Wang. (2009) Differential bone marrow stem cell mobilization by G-CSF injection or arterial ligation in baboons. Journal of Cellular and Molecular Medicine 13:8b, 1896-1906
CrossRef260
Xiao-qin Liu, Guo-ying Huang, Xue-cun Liang, Xiao-jing Ma. (2009) Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease. Acta Paediatrica 98:8, 1355-1359
CrossRef261
J. S. Silvestre, B. I. Levy. (2009) Circulating progenitor cells and cardiovascular outcomes: latest evidence on angiotensin-converting enzyme inhibitors. European Heart Journal Supplements 11:Suppl E, E17-E21
CrossRef262
Emeline M. Van Craenenbroeck, Johan Denollet, Bernard P. Paelinck, Paul Beckers, Nadine Possemiers, Vicky Y. Hoymans, Christiaan J. Vrints, Viviane M. Conraads. (2009) Circulating CD34 + /KDR + endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. Clinical Science 117:4, 165-172
CrossRef263
Eduard Shantsila, Gregory Y.H. Lip. (2009) Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?. European Journal of Cardiovascular Prevention & Rehabilitation 16:4, 401-403
CrossRef264
Atsushi Honda, Katsuhisa Matsuura, Noritoshi Fukushima, Yukio Tsurumi, Hiroshi Kasanuki, Nobuhisa Hagiwara. (2009) Telmisartan induces proliferation of human endothelial progenitor cells via PPARγ-dependent PI3K/Akt pathway. Atherosclerosis 205:2, 376-384
CrossRef265
T Ioka, S Tsuruoka, C Ito, H Iwaguro, T Asahara, A Fujimura, E Kusano. (2009) Hypertension Induced by Erythropoietin Has a Correlation With Truncated Erythropoietin Receptor mRNA in Endothelial Progenitor Cells of Hemodialysis Patients. Clinical Pharmacology & Therapeutics 86:2, 154-159
CrossRef266
Tatsiana Suvorava, Georg Kojda. (2009) Reactive oxygen species as cardiovascular mediators: Lessons from endothelial-specific protein overexpression mouse models. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1787:7, 802-810
CrossRef267
B. Hibbert, X. Ma, A. Pourdjabbar, E. Holm, K. Rayner, Y.-X. Chen, J. Sun, L. Filion, E. R. O'Brien. (2009) Inhibition of endothelial progenitor cell glycogen synthase kinase-3 results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovascular Research 83:1, 16-23
CrossRef268
Margo Klomp, Marcel AM Beijk, Robbert J de Winter. (2009) Genous™ endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Review of Medical Devices 6:4, 365-375
CrossRef269
P. Muller, A. Kazakov, P. Jagoda, A. Semenov, M. Bohm, U. Laufs. (2009) ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. Cardiovascular Research 83:1, 106-114
CrossRef270
James E. Rider, Sean P. Polster, Sangjin Lee, Nathan J. Charles, Neeta Adhikari, Ami Mariash, George Tadros, Jenna Stangland, Ryszard T. Smolenski, Cesare M Terracciano, Paul J.R. Barton, Emma J. Birks, Magdi H. Yacoub, Leslie W. Miller, Jennifer L. Hall. (2009) Chronic Treatment with Clenbuterol Modulates Endothelial Progenitor Cells and Circulating Factors in a Murine Model of Cardiomyopathy. Journal of Cardiovascular Translational Research 2:2, 182-190
CrossRef271
Pedro R. Moreno, Javier Sanz, Valentin Fuster. (2009) Promoting Mechanisms of Vascular Health. Journal of the American College of Cardiology 53:25, 2315-2323
CrossRef272
Rieko Mano, Akio Ishida, Yusuke Ohya, Hidemi Todoriki, Shuichi Takishita. (2009) Dietary intervention with Okinawan vegetables increased circulating endothelial progenitor cells in healthy young women. Atherosclerosis 204:2, 544-548
CrossRef273
Mamoru Satoh, Yoshitaka Minami, Yuji Takahashi, Tsuyoshi Tabuchi, Tomonori Itoh, Motoyuki Nakamura. (2009) Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clinical Science 116:11, 827-835
CrossRef274
G. Schernthaner. (2009) Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors. International Journal of Clinical Practice 63:6, 912-929
CrossRef275
Peter E. Westerweel, Marianne C. Verhaar. (2009) Endothelial progenitor cell dysfunction in rheumatic disease. Nature Reviews Rheumatology 5:6, 332-340
CrossRef276
Nicola Smart, Karina N. Dubé, Paul R. Riley. (2009) Coronary vessel development and insight towards neovascular therapy. International Journal of Experimental Pathology 90:3, 262-283
CrossRef277
Jianfei Chen, Lan Huang, Minbao Song, Shiyong Yu, Pan Gao, Jun Jing. (2009) C-reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression and Alters Antioxidant Defenses in Rat Endothelial Progenitor Cells. Journal of Cardiovascular Pharmacology 53:5, 359-367
CrossRef278
Domenico Scrutinio, Pier Luigi Temporelli, Andrea Passantino, Pantaleo Giannuzzi. (2009) Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity. Future Cardiology 5:3, 297-314
CrossRef279
Johannes C. Fischer, Brigitte M. Kudielka, Roland von Känel, Johannes Siegrist, Julian F. Thayer, Joachim E. Fischer. (2009) Bone-marrow derived progenitor cells are associated with psychosocial determinants of health after controlling for classical biological and behavioral cardiovascular risk factors. Brain, Behavior, and Immunity 23:4, 419-426
CrossRef280
Y. Minami, M. Satoh, C. Maesawa, Y. Takahashi, T. Tabuchi, T. Itoh, M. Nakamura. (2009) Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. European Journal of Clinical Investigation 39:5, 359-367
CrossRef281
Stefan A.J. Timmer, Karin De Boer, Paul Knaapen, Marco J.W. Götte, A.C. Van Rossum. (2009) The Potential Role of Erythropoietin in Chronic Heart Failure: From the Correction of Anemia to Improved Perfusion and Reduced Apoptosis?. Journal of Cardiac Failure 15:4, 353-361
CrossRef282
Evgenios Goussetis, Antonia Spiropoulos, Maria Tsironi, Katerina Skenderi, Alexandra Margeli, Stelios Graphakos, Panayiotis Baltopoulos, Ioannis Papassotiriou. (2009) Spartathlon, a 246 kilometer foot race: Effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells. Blood Cells, Molecules, and Diseases 42:3, 294-299
CrossRef283
Gian Paolo Fadini, Carlo Agostini, Angelo Avogaro. (2009) Critical confounders in the prognostic role of cellular biomarkers. Kidney International 75:7, 755-755
CrossRef284
Marc R. Lilien, Jaap W. Groothoff. (2009) Cardiovascular disease in children with CKD or ESRD. Nature Reviews Nephrology 5:4, 229-235
CrossRef285
Pengxia Liu, Bin Zhou, Dongsheng Gu, Lei Zhang, Zhongchao Han. (2009) Endothelial progenitor cell therapy in atherosclerosis: A double-edged sword?. Ageing Research Reviews 8:2, 83-93
CrossRef286
Njeri Thande, Robert S Rosenson. (2009) Vascular biomarkers in the metabolic syndrome. Expert Review of Molecular Diagnostics 9:3, 209-215
CrossRef287
Martin Steinmetz, Georg Nickenig, Nikos Werner. (2009) Perspektiven regenerativer Mechanismen bei Herz-Kreislauf-Erkrankungen am Beispiel endothelialer Progenitorzellen. Medizinische Klinik 104:4, 287-295
CrossRef288
Wing Y. Tam, Ping Chook, Mu Qiao, Lin T. Chan, Thomas Y.K. Chan, Yam K. Poon, Kwok P. Fung, Ping C. Leung, Kam S. Woo. (2009) The Efficacy and Tolerability of Adjunctive Alternative Herbal Medicine ( Salvia miltiorrhiza and Pueraria lobata ) on Vascular Function and Structure in Coronary Patients. The Journal of Alternative and Complementary Medicine 15:4, 415-421
CrossRef289
Magnus Baumhäkel, Nils Schlimmer, Mario T. Kratz, Michael Böhm. (2009) Erektile Dysfunktion: Indikator für Endorganschädigung beim kardiovaskulären Patienten. Medizinische Klinik 104:4, 309-313
CrossRef290
Mariana J. Kaplan. (2009) Management of cardiovascular disease risk in chronic inflammatory disorders. Nature Reviews Rheumatology 5:4, 208-217
CrossRef291
Shoichi Maruyama, Akihiko Taguchi. (2009) Response to ‘Critical confounders in the prognostic role of cellular biomarkers’. Kidney International 75:7, 755-756
CrossRef292
Ai-wu Shi, Xiao-bin Wang, Feng-xiang Lu, Min-min Zhu, Xiang-qing Kong, Ke-jiang Cao. (2009) Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation. Acta Pharmacologica Sinica 30:3, 299-306
CrossRef293
Marta Mosca, Agostino Virdis, Chiara Tani, Lorenzo Ghiadoni, Daniele Versari, Emiliano Duranti, Anna d’Ascanio, Antonio Salvetti, Stefano Taddei, Stefano Bombardieri. (2009) Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis 203:1, 185-191
CrossRef294
F. Sabatier, L. Camoin-Jau, F. Anfosso, J. Sampol, F. Dignat-George. (2009) Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. Journal of Cellular and Molecular Medicine 13:3, 454-471
CrossRef295
Pascal J. Goldschmidt-Clermont. (2009) Jay and Jeanie Schottenstein Prize in Cardiovascular Science: Predicting Cardiovascular Illnesses for the 21 st Century, and the Unpredictable …. Antioxidants & Redox Signaling 11:3, 401-406
CrossRef296
M Sasahara, A Otani, Y Yodoi, N Gotoh, T Kameda, N Yoshimura. (2009) Circulating hematopoietic stem cells in patients with choroidal neovascularization secondary to pathologic myopia. Eye 23:3, 718-726
CrossRef297
Oscar Moreno-Pérez, Antonio Miguel Picó Alfonso, Joaquín Portilla. (2009) Hipogonadismo, disfunción eréctil y disfunción endotelial en varones con infección por el virus de la inmunodeficiencia humana. Medicina Clínica 132:8, 311-321
CrossRef298
Amy Atkeson, Susie Yim Yeh, Atul Malhotra, Sanja Jelic. (2009) Endothelial Function in Obstructive Sleep Apnea. Progress in Cardiovascular Diseases 51:5, 351-362
CrossRef299
K. Stellos, B. Bigalke, H. Langer, T. Geisler, A. Schad, A. Kogel, F. Pfaff, D. Stakos, P. Seizer, I. Muller, P. Htun, S. Lindemann, M. Gawaz. (2009) Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. European Heart Journal 30:5, 584-593
CrossRef300
Takeshi Nishikawa, Nelson H. Tsuno, Takeshi Tsuchiya, Satomi Yoneyama, Jun Yamada, Yasutaka Shuno, Yurai Okaji, Junichiro Tanaka, Joji Kitayama, Koki Takahashi, Hirokazu Nagawa. (2009) Sulforaphane Stimulates Activation of Proapoptotic Protein Bax Leading to Apoptosis of Endothelial Progenitor Cells. Annals of Surgical Oncology 16:2, 534-543
CrossRef301
A. Larena-Avellaneda, M. Winkler, T. Shimizu, M.A. Reidy, G. Daum. (2009) Mausmodelle zur Erforschung der Intimahyperplasie. Gefässchirurgie 14:1, 9-15
CrossRef302
Chad Tang, Faina Kligman, Coby C. Larsen, Kandice Kottke-Marchant, Roger E. Marchant. (2009) Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification. Journal of Biomedical Materials Research Part A 88A:2, 348-358
CrossRef303
H.E. Thomas, G. Parry, J.H. Dark, H.M. Arthur, B.D. Keavney. (2009) Circulating endothelial progenitor cell numbers are not associated with donor organ age or allograft vasculopathy in cardiac transplant recipients. Atherosclerosis 202:2, 612-616
CrossRef304
Thomas J. Povsic, Katherine L. Zavodni, Enrikas Vainorius, Jennifer F. Kherani, Pascal J. Goldschmidt-Clermont, Eric D. Peterson. (2009) Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. American Heart Journal 157:2, 335-344
CrossRef305
J. D. PEARSON. (2009) Endothelial progenitor cells - hype or hope?. Journal of Thrombosis and Haemostasis 7:2, 255-262
CrossRef306
O J MacEneaney, E J Kushner, G P Van Guilder, J J Greiner, B L Stauffer, C A DeSouza. (2009) Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. International Journal of Obesity 33:2, 219-225
CrossRef307
Yonggang Wu, Qiru Wang, Lamei Cheng, Jian Wang, Guangxiu Lu. (2009) Effect of Oxidized Low-density Lipoprotein on Survival and Function of Endothelial Progenitor Cell Mediated by p38 Signal Pathway. Journal of Cardiovascular Pharmacology 53:2, 151-156
CrossRef308
Gian Paolo Fadini, Carlo Agostini, Elisa Boscaro, Angelo Avogaro. (2009) Mechanisms and Significance of Progenitor Cell Reduction in the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 7:1, 5-10
CrossRef309
Giulio Coluzzi, Eleonora Santucci, Francesca Marzo, Felicita Andreotti. (2009) Asymmetric dimethylarginine and impaired cardiovascular healing. Journal of Thrombosis and Thrombolysis 27:2, 168-171
CrossRef310
S. Vöö, M. Dunaeva, J. Eggermann, N. Stadler, J. Waltenberger. (2009) Diabetes mellitus impairs CD133 + progenitor cell function after myocardial infarction. Journal of Internal Medicine 265:2, 238-249
CrossRef311
Kim E. Jie, Michèle H.J. Goossens, Olivia van Oostrom, Marc R. Lilien, Marianne C. Verhaar. (2009) Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis 202:2, 345-347
CrossRef312
Giulio Pompilio, Maurizio C Capogrossi, Maurizio Pesce, Francesco Alamanni, Cristiana DiCampli, Felice Achilli, Antonia Germani, Paolo Biglioli. (2009) Endothelial progenitor cells and cardiovascular homeostasis: Clinical implications. International Journal of Cardiology 131:2, 156-167
CrossRef313
Takanori Yasu. (2009) Differentiation of Endothelial Progenitor Cells. Circulation Journal 73:7, 1199-1200
CrossRef314
James E. Novak, Lynda A. Szczech. (2009) Phosphate Binders in Chronic Kidney Disease and End-Stage Renal Disease: A Patient-Centered Approach. Seminars in Dialysis 22:1, 56-63
CrossRef315
Frank Timmermans, Jean Plum, Mervin C. Yöder, David A. Ingram, Bart Vandekerckhove, Jamie Case. (2009) Endothelial progenitor cells: identity defined?. Journal of Cellular and Molecular Medicine 13:1, 87-102
CrossRef316
Yukihito HIGASHI. (2009) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 40:4, 201S-202S
CrossRef317
Akihiko Taguchi, Nami Nakagomi, Tomohiro Matsuyama, Akie Kikuchi-Taura, Hiroo Yoshikawa, Yukiko Kasahara, Haruka Hirose, Hiroshi Moriwaki, Takayuki Nakagomi, Toshihiro Soma, David M Stern, Hiroaki Naritomi. (2009) Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction. Journal of Cerebral Blood Flow & Metabolism 29:1, 34-38
CrossRef318
Christopher J. Rhodes, Alexandra Davidson, J. Simon R. Gibbs, John Wharton, Martin R. Wilkins. (2009) Therapeutic targets in pulmonary arterial hypertension. Pharmacology & Therapeutics 121:1, 69-88
CrossRef319
Katherine Esposito, Miryam Ciotola, Maria Ida Maiorino, Francesco Giugliano, Riccardo Autorino, Marco De Sio, Emmanuele Jannini, Andrea Lenzi, Dario Giugliano. (2009) Circulating CD34 + KDR + Endothelial Progenitor Cells Correlate with Erectile Function and Endothelial Function in Overweight Men. Journal of Sexual Medicine 6:1, 107-114
CrossRef320
Erich J. Kushner, Gary P. Van Guilder, Owen J. MacEneaney, Jennifer N. Cech, Brian L. Stauffer, Christopher A. DeSouza. (2009) Aging and endothelial progenitor cell telomere length in healthy men. Clinical Chemistry and Laboratory Medicine 47:1, 47-50
CrossRef321
Richa Tripathi, Gayatri Rath, Ranju Ralhan, Sunita Saxena, Sudha Salhan. (2009) Soluble and Membranous Vascular Endothelial Growth Factor Receptor-2 in Pregnancies Complicated by Pre-Eclampsia. Yonsei Medical Journal 50:5, 656
CrossRef322
Zheqing Cai, Gregg L. Semenza. 2009. Extra-Hematopoietic Action of Erythropoietin. , 27-33.
CrossRef323
Shoichi Maruyama, Akihiko Taguchi, Shigejiro Iwashima, Takenori Ozaki, Kaoru Yasuda, Akie Kikuchi-Taura, Toshihiro Soma, Hideki Ishii, Toyoaki Murohara, Hiroshi Takahashi, Hirotake Kasuga, Yoshitaka Kumada, Takanobu Toriyama, Yasuhiko Ito, Hirohisa Kawahara, Yukio Yuzawa, Seiichi Matsuo. (2008) Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney International 74:12, 1603-1609
CrossRef324
Michael J. Guzman, Paul R. Crisostomo, Meijing Wang, Troy A. Markel, Yue Wang, Daniel R. Meldrum. (2008) Vascular Endothelial Growth Factor Improves Myocardial Functional Recovery Following Ischemia/Reperfusion Injury. Journal of Surgical Research 150:2, 286-292
CrossRef325
Roberto Latini, Michael Brines, Fabio Fiordaliso. (2008) Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?. Heart Failure Reviews 13:4, 415-423
CrossRef326
Dimitris Tousoulis, Ioannis Andreou, Charalambos Antoniades, Costas Tentolouris, Christodoulos Stefanadis. (2008) Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: Therapeutic implications for cardiovascular diseases. Atherosclerosis 201:2, 236-247
CrossRef327
Christian Werner, Michael Böhm, Erik B. Friedrich. (2008) Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease. Biochemical and Biophysical Research Communications 377:2, 331-336
CrossRef328
Antonio Maria Leone, Sergio Rutella, Maria Benedetta Giannico, Matteo Perfetti, Vincenzo Zaccone, Salvatore Brugaletta, Barbara Garramone, Giampaolo Niccoli, Italo Porto, Giovanna Liuzzo, Luigi Marzio Biasucci, Silvia Bellesi, Leonarda Galiuto, Giuseppe Leone, Antonio Giuseppe Rebuzzi, Filippo Crea. (2008) Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. International Journal of Cardiology 130:3, 457-462
CrossRef329
Stefan Brunner, Markus G Engelmann, Wolfgang-Michael Franz. (2008) Stem cell mobilisation for myocardial repair. Expert Opinion on Biological Therapy 8:11, 1675-1690
CrossRef330
Takashi Umemura, Junko Soga, Takayuki Hidaka, Hiroaki Takemoto, Shuji Nakamura, Daisuke Jitsuiki, Kenji Nishioka, Chikara Goto, Hiroki Teragawa, Masao Yoshizumi, Kazuaki Chayama, Yukihito Higashi. (2008) Aging and Hypertension Are Independent Risk Factors for Reduced Number of Circulating Endothelial Progenitor Cells. American Journal of Hypertension 21:11, 1203-1209
CrossRef331
Laura S. Haneline. (2008) Redox Regulation of Stem and Progenitor Cells. Antioxidants & Redox Signaling 10:11, 1849-1852
CrossRef332
A. Tiengo, G.P. Fadini, A. Avogaro. (2008) The metabolic syndrome, diabetes and lung dysfunction. Diabetes & Metabolism 34:5, 447-454
CrossRef333
Selcuk Sozer, Xiaoli Wang, Wei Zhang, Maria Isabel Fiel, Takefumi Ishii, Jiapeng Wang, Nathaniel Wisch, Mingjiang Xu, Ronald Hoffman. (2008) Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders. Blood Cells, Molecules, and Diseases 41:3, 284-291
CrossRef334
Cheen P Khoo, Paolo Pozzilli, Malcolm R Alison. (2008) Endothelial progenitor cells and their potential therapeutic applications. Regenerative Medicine 3:6, 863-876
CrossRef335
Brian L. Stauffer, Owen J. MacEneaney, Erich J. Kushner, Jennifer N. Cech, Jared J. Greiner, Christian M. Westby, Christopher A. DeSouza. (2008) Gender and endothelial progenitor cell number in middle-aged adults. Artery Research 2:4, 156-160
CrossRef336
Rui Hu, Wei-Qun Wang, Chu-Pak Lau, Hung-Fat Tse. (2008) Gender Differences on Brachial Flow-mediated Dilation and Carotid Intima-media Thickness for Prediction of Spontaneous Cardiovascular Events. Clinical Cardiology 31:11, 525-530
CrossRef337
Stefanie Keymel, Christoph Kalka, Tienush Rassaf, Yerem Yeghiazarians, Malte Kelm, Christian Heiss. (2008) Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Research in Cardiology 103:6, 582-586
CrossRef338
Jamie Case, David A. Ingram, Laura S. Haneline. (2008) Oxidative Stress Impairs Endothelial Progenitor Cell Function. Antioxidants & Redox Signaling 10:11, 1895-1907
CrossRef339
D. A. Taylor, A. G. Zenovich. (2008) Cardiovascular cell therapy and endogenous repair. Diabetes, Obesity and Metabolism 10, 5-15
CrossRef340
Troy A. Markel, Paul R. Crisostomo, Tim Lahm, Nathan M. Novotny, Frederick J. Rescorla, Joseph Tector, Daniel R. Meldrum. (2008) Stem cells as a potential future treatment of pediatric intestinal disorders. Journal of Pediatric Surgery 43:11, 1953-1963
CrossRef341
Shane R. Thomas, Paul K. Witting, Grant R. Drummond. (2008) Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities. Antioxidants & Redox Signaling 10:10, 1713-1766
CrossRef342
Mario Gössl, Ulrike I. Mödder, Elizabeth J. Atkinson, Amir Lerman, Sundeep Khosla. (2008) Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis. Journal of the American College of Cardiology 52:16, 1314-1325
CrossRef343
Tohru Minamino, Issei Komuro. (2008) Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nature Clinical Practice Cardiovascular Medicine 5:10, 637-648
CrossRef344
J.B. Richards, A.M. Valdes, J.P. Gardner, B.S. Kato, A. Siva, M. Kimura, X. Lu, M.J. Brown, A. Aviv, T.D. Spector. (2008) Homocysteine levels and leukocyte telomere length. Atherosclerosis 200:2, 271-277
CrossRef345
Mihail Hristov, Christian Weber. (2008) Ambivalence of progenitor cells in vascular repair and plaque stability. Current Opinion in Lipidology 19:5, 491-497
CrossRef346
Amish N. Raval, Timothy J. Kamp, Linda F. Hogle. (2008) Cellular therapies for heart disease: Unveiling the ethical and public policy challenges. Journal of Molecular and Cellular Cardiology 45:4, 593-601
CrossRef347
Kentaro Jujo, Masaaki Ii, Douglas W. Losordo. (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. Journal of Molecular and Cellular Cardiology 45:4, 530-544
CrossRef348
A. M. Leone, M. Valgimigli, M. B. Giannico, V. Zaccone, M. Perfetti, D. D'Amario, A. G. Rebuzzi, F. Crea. (2008) From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. European Heart Journal 30:8, 890-899
CrossRef349
Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, G. Schuler. (2008) Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair. European Heart Journal 30:3, 346-355
CrossRef350
RICHARD F. SPAIDE. (2008) THE POTENTIAL OF PLURIPOTENT CELLS IN VITREORETINAL DISEASES. Retina 28:8, 1031-1034
CrossRef351
Simona Marcheselli, Giuseppe Micieli. (2008) Renin-angiotensin system and stroke. Neurological Sciences 29:S2, 277-278
CrossRef352
Christian Besler, Carola Doerries, Giovanna Giannotti, Thomas F Lüscher, Ulf Landmesser. (2008) Pharmacological approaches to improve endothelial repair mechanisms. Expert Review of Cardiovascular Therapy 6:8, 1071-1082
CrossRef353
Laurent Bonello, Axel De Labriolle, Probal Roy, Daniel H. Steinberg, Teruo Okabe, Tina L. Pinto Slottow, Zhenyi Xue, Rebecca Torguson, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2008) Impact of Optimal Medical Therapy and Revascularization on Outcome of Patients With Chronic Kidney Disease and on Dialysis Who Presented With Acute Coronary Syndrome. The American Journal of Cardiology 102:5, 535-540
CrossRef354
Dael Geft, Shmuel Schwartzenberg, Jacob George. (2008) Circulating endothelial progenitor cells in cardiovascular disorders. Expert Review of Cardiovascular Therapy 6:8, 1115-1121
CrossRef355
Afroze Abbas, Peter J Grant, Mark T Kearney. (2008) Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Review of Cardiovascular Therapy 6:8, 1135-1149
CrossRef356
J. Grisar, C. W. Steiner, M. Bonelli, T. Karonitsch, I. Schwarzinger, G. Weigel, G. Steiner, J. S. Smolen. (2008) Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology 47:10, 1476-1483
CrossRef357
Adriano Taddeo, Pietro Presicce, Lucia Brambilla, Monica Bellinvia, Maria L Villa, Silvia Della Bella. (2008) Circulating Endothelial Progenitor Cells Are Increased in Patients with Classic Kaposi's Sarcoma. Journal of Investigative Dermatology 128:8, 2125-2128
CrossRef358
Anantha Vijay R. Santhanam, Livius V. d’Uscio, Timothy E. Peterson, Zvonimir S. Katusic. (2008) Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells. Peptides 29:8, 1451-1455
CrossRef359
Sahena Haque, Hoda Mirjafari, Ian N Bruce. (2008) Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Current Opinion in Lipidology 19:4, 338-343
CrossRef360
Simona Sacco, Davide Cerone, Antonio Carolei. (2008) Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. The Journal of Headache and Pain 9:4, 237-248
CrossRef361
Claudia Walther, Volker Adams, Inga Bothur, Kati Drechsler, Sven Fikenzer, Melanie Sonnabend, Beatrice Bublitz, Antje Körner, Sandra Erbs, Martin Busse, Gerhard Schuler. (2008) Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells. European Journal of Cardiovascular Prevention & Rehabilitation 15:4, 416-422
CrossRef362
Bruno K. Podesser, Michael Bauer, Ronglih Liao. (2008) Evolving cell-based therapies for heart failure patients. Current Treatment Options in Cardiovascular Medicine 10:4, 358-367
CrossRef363
Barry A Boilson, Thomas J Kiernan, Adriana Harbuzariu, Rebecca E Nelson, Amir Lerman, Robert D Simari. (2008) Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nature Clinical Practice Cardiovascular Medicine 5:8, 489-496
CrossRef364
Francesca Cesari, Roberto Caporale, Rossella Marcucci, Sabina Caciolli, Pier Luigi Stefano, Andrea Capalbo, Claudio Macchi, Mauro Vannucci, Gian Franco Gensini, Rosanna Abbate, Anna Maria Gori. (2008) NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells’ response to cardiac surgery. Atherosclerosis 199:1, 138-146
CrossRef365
Mihail Hristov, Alma Zernecke, Andreas Schober, Christian Weber. (2008) Adult progenitor cells in vascular remodeling during atherosclerosis. Biological Chemistry 389:7, 837-844
CrossRef366
Matteo Mariani, Stefano De Servi, Rosa Chianese, Gabriella Beria, Arianna Gatti, Fabrizio Poletti, Gianfranco Del Rosso, Raffaela Fetiveau, Arnaldo Poli, Maurizio Macchi, Bruno Brando. (2008) Circulating CD34-positive cell number is related to effective myocardial reperfusion in acute myocardial infarction treated with primary coronary angioplasty. Journal of Cardiovascular Medicine 9:7, 677-682
CrossRef367
Laura E. Mead, Daniel Prater, Mervin C. Yoder, David A. Ingram. 2008. Isolation and Characterization of Endothelial Progenitor Cells from Human Blood. .
CrossRef368
M JAWAD JAVED, LAURA E. MEAD, DANIEL PRATER, WAYLAN K. BESSLER, DAVID FOSTER, JAMIE CASE, W SCOTT GOEBEL, MERVIN C. YODER, LAURA S. HANELINE, DAVID A. INGRAM. (2008) Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood. Pediatric Research 64:1, 68-73
CrossRef369
Mario Romano. (2008) Inflammation resolution: Does the bone marrow have a say?. American Journal of Hematology 83:6, 435-436
CrossRef370
Timothy Watson, Patrick K.Y. Goon, Gregory Y.H. Lip. (2008) Endothelial Progenitor Cells, Endothelial Dysfunction, Inflammation, and Oxidative Stress in Hypertension. Antioxidants & Redox Signaling 10:6, 1079-1088
CrossRef371
Mamoru Satoh, Yuh Ishikawa, Yuji Takahashi, Tomonori Itoh, Yoshitaka Minami, Motoyuki Nakamura. (2008) Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198:2, 347-353
CrossRef372
Brian W. McCrindle, Cedric Manlhiot. (2008) Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment. Journal of Clinical Lipidology 2:3, 138-146
CrossRef373
Jessica K. Devin, Douglas E. Vaughan, Lewis S. Blevins, Qingxia Chen, Joseph Covington, Denise K. Verity, Pampee P. Young. (2008) Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Hormone & IGF Research 18:3, 253-263
CrossRef374
Maria Luisa Balestrieri, Monica Rienzo, Francesca Felice, Raffaele Rossiello, Vincenzo Grimaldi, Lara Milone, Amelia Casamassimi, Luigi Servillo, Bartolomeo Farzati, Alfonso Giovane, Claudio Napoli. (2008) High glucose downregulates endothelial progenitor cell number via SIRT1. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784:6, 936-945
CrossRef375
Christopher R. Cogle, Gerard J. Madlambayan, Grant Hubsher, Chris Beckman, Rachel Speisman, Roger Tran-Son-Tay, Carl J. Pepine. (2008) Marrow cell therapies for cardiovascular diseases. Experimental Hematology 36:6, 687-694
CrossRef376
Glenn Marsboom, Stefan Janssens. (2008) Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Expert Review of Cardiovascular Therapy 6:5, 687-701
CrossRef377
P. E. Westerweel, F. L.J. Visseren, G. R. Hajer, J. K. Olijhoek, I. E. Hoefer, P. de Bree, S. Rafii, P. A. Doevendans, M. C. Verhaar. (2008) Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. European Heart Journal 29:22, 2808-2817
CrossRef378
A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, J. S. Dubiel. (2008) Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina. Nephrology Dialysis Transplantation 23:7, 2265-2273
CrossRef379
F. Santilli, M. Romano, A. Recchiuti, A. Dragani, A. Falco, G. Lessiani, F. Fioritoni, S. Lattanzio, D. Mattoscio, R. De Cristofaro, B. Rocca, G. Davi. (2008) Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood 112:4, 1085-1090
CrossRef380
Christian Heiss, Maelene L. Wong, Vanessa I. Block, David Lao, Wendy May Real, Yerem Yeghiazarians, Randall J. Lee, Matthew L. Springer. (2008) Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. Journal of Cellular Physiology 215:2, 366-373
CrossRef381
Jerome G. Roncalli, Jörn Tongers, Marie-Ange Renault, Douglas W. Losordo. (2008) Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends in Biotechnology 26:5, 276-283
CrossRef382
J Avouac, Y Allanore. (2008) Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opinion on Pharmacotherapy 9:7, 1121-1128
CrossRef383
T D Strong, M A Gebska, H C Champion, A L Burnett, T J Bivalacqua. (2008) Stem and endothelial progenitor cells in erection biology. International Journal of Impotence Research 20:3, 243-254
CrossRef384
A. Liew, J. H. McDermott, F. Barry, T. O’Brien. (2008) Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora’s box?. Diabetes, Obesity and Metabolism 10:5, 353-366
CrossRef385
David S. Celermajer, Martin K.C. Ng. (2008) Where There's Smoke...
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 51:18, 1772-1774
CrossRef386
G. Schlieper, M. Hristov, V. Brandenburg, T. Kruger, R. Westenfeld, A. H. Mahnken, E. Yagmur, G. Boecker, N. Heussen, U. Gladziwa, M. Ketteler, C. Weber, J. Floege. (2008) Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrology Dialysis Transplantation 23:8, 2611-2618
CrossRef387
De-Guang Yang, Ling Liu, Xiao-Yan Zheng. (2008) Cyclin-dependent kinase inhibitor p16INK4a and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Research Reviews 7:2, 137-146
CrossRef388
Matteo Pirro, Giuseppe Schillaci, Francesco Bagaglia, Cinzia Menecali, Rita Paltriccia, Massimo R. Mannarino, Marusca Capanni, Andrea Velardi, Elmo Mannarino. (2008) Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 197:2, 757-767
CrossRef389
Toshio Imanishi, Katsunobu Kobayashi, Akio Kuroi, Hideyuki Ikejima, Takashi Akasaka. (2008) Pioglitazone Inhibits Angiotensin II–Induced Senescence of Endothelial Progenitor Cell. Hypertension Research 31:4, 757-765
CrossRef390
Gian Paolo Fadini, Ilenia Baesso, Mattia Albiero, Saverio Sartore, Carlo Agostini, Angelo Avogaro. (2008) Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 197:2, 496-503
CrossRef391
Rohit M Oemrawsingh, K Martijn Akkerhuis, Eric Boersma. (2008) Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management. Expert Review of Cardiovascular Therapy 6:4, 435-437
CrossRef392
Emeline M.F. Van Craenenbroeck, Viviane M.A. Conraads, Dirk R. Van Bockstaele, Steven E. Haine, Katrien Vermeulen, Viggo F. Van Tendeloo, Christiaan J. Vrints, Vicky Y. Hoymans. (2008) Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches. Journal of Immunological Methods 332:1-2, 31-40
CrossRef393
A Oliveras, M J Soler, O M Martínez-Estrada, S Vázquez, D Marco-Feliu, J S Vila, S Vilaró, J Lloveras. (2008) Endothelial progenitor cells are reduced in refractory hypertension. Journal of Human Hypertension 22:3, 183-190
CrossRef394
Antonio Liguori, Carmela Fiorito, Maria Luisa Balestrieri, Ettore Crimi, Giuseppe Bruzzese, Sharon Williams-Ignarro, Maurizio D’Amora, Linda Sommese, Vincenzo Grimaldi, Pellegrino Biagio Minucci, Alfonso Giovane, Bartolomeo Farzati, Louis J. Ignarro, Claudio Napoli. (2008) Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. European Journal of Haematology 80:3, 258-264
CrossRef395
Gregorio Brevetti, Vittorio Schiano, Massimo Chiariello. (2008) Endothelial dysfunction: A key to the pathophysiology and natural history of peripheral arterial disease?. Atherosclerosis 197:1, 1-11
CrossRef396
Jérôme Avouac, Georges Uzan, André Kahan, Catherine Boileau, Yannick Allanore. (2008) Progéniteurs endothéliaux et maladies rhumatismales. Revue du Rhumatisme 75:3, 207-213
CrossRef397
Jon Smythe, Andreas Fox, Nita Fisher, Emma Frith, Adrian L. Harris, Suzanne M. Watt. (2008) Measuring Angiogenic Cytokines, Circulating Endothelial Cells, and Endothelial Progenitor Cells in Peripheral Blood and Cord Blood: VEGF and CXCL12 Correlate with the Number of Circulating Endothelial Progenitor Cells in Peripheral Blood. Tissue Engineering Part C: Methods 14:1, 59-67
CrossRef398
Jérôme Avouac, Georges Uzan, André Kahan, Catherine Boileau, Yannick Allanore. (2008) Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 75:2, 131-137
CrossRef399
Akihiko Taguchi, Tomohiro Matsuyama, Takayuki Nakagomi, Yoko Shimizu, Ryuzo Fukunaga, Yoshiaki Tatsumi, Hiroo Yoshikawa, Akie Kikuchi-Taura, Toshihiro Soma, Hiroshi Moriwaki, Kazuyuki Nagatsuka, David M Stern, Hiroaki Naritomi. (2008) Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment. Journal of Cerebral Blood Flow & Metabolism 28:3, 445-449
CrossRef400
A Cortelezzi, G Gritti, N Del Papa, M C Pasquini, R Calori, U Gianelli, M Cortiana, G Parati, F Onida, F Sozzi, C Vener, P Bianchi, G L Deliliers. (2008) Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. Leukemia 22:3, 646-649
CrossRef401
Farhad Haghighi Rad, Ayhan Ulusakarya, Sophie Gad, Mathilde Sibony, Fabrice Juin, Stéphane Richard, David Machover, Georges Uzan. (2008) Novel somatic mutations of theVHL gene in an erythropoietin-producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells. American Journal of Hematology 83:2, 155-158
CrossRef402
Christian Werner, Michael Böhm, Erik B Friedrich. (2008) Progenitor cell therapy and myocardial infarction: the importance of microvascular function. Nature Clinical Practice Cardiovascular Medicine 5:2, 78-79
CrossRef403
A. Linke, R. Hambrecht. (2008) Notwendigkeit von körperlicher Aktivität als Baustein der Prävention. Der Kardiologe 2:1, 17-27
CrossRef404
M. Jevon, A. Dorling, P. I. Hornick. (2008) Progenitor cells and vascular disease. Cell Proliferation 41, 146-164
CrossRef405
Christian Pagnoux, Gilles Chironi, Alain Simon, Loïc Guillevin. (2008) Link between small-vessel vasculitides and atherosclerosis. Future Lipidology 3:1, 83-95
CrossRef406
Hans D. Theiss, Michaela Adam, Sven Greie, Wolfgang Schobersberger, Egon Humpeler, Wolfgang-M. Franz. (2008) Increased levels of circulating progenitor cells after 1-week sojourn at moderate altitude (Austrian Moderate Altitude Study II, AMAS II). Respiratory Physiology & Neurobiology 160:2, 232-238
CrossRef407
Nana Mukai, Taichi Akahori, Motohiro Komaki, Qin Li, Toshie Kanayasu-Toyoda, Akiko Ishii-Watabe, Akiko Kobayashi, Teruhide Yamaguchi, Mayumi Abe, Teruo Amagasa, Ikuo Morita. (2008) A comparison of the tube forming potentials of early and late endothelial progenitor cells. Experimental Cell Research 314:3, 430-440
CrossRef408
M. GAWAZ, K. STELLOS, H. F. LANGER. (2008) Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. Journal of Thrombosis and Haemostasis 6:2, 235-242
CrossRef409
J. Muller-Ehmsen, D. Braun, T. Schneider, R. Pfister, N. Worm, K. Wielckens, C. Scheid, P. Frommolt, M. Flesch. (2008) Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. European Heart Journal 29:12, 1560-1568
CrossRef410
K Nayan S Rao, Azan S Binbrek, Burton E Sobel. (2008) Heart disease and erythropoietin. Future Cardiology 4:1, 57-64
CrossRef411
Amish N Raval. (2008) Therapeutic Potential of Adult Progenitor Cells in the Management of Chronic Myocardial Ischemia. American Journal of Cardiovascular Drugs 8:5, 315-326
CrossRef412
Keun-Hwa Jung, Jae-Kyu Roh. (2008) Circulating Endothelial Progenitor Cells in Cerebrovascular Disease. Journal of Clinical Neurology 4:4, 139
CrossRef413
Kitipan V. Arom, Permyos Ruengsakulrach, Vibul Jotisakulratana. (2008) Efficacy of Intramyocardial Injection of Angiogenic Cell Precursors for Ischemic Cardiomyopathy. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 3:1, 38-45
CrossRef414
Yi Yu, Noboru Fukuda, En-Hui Yao, Taro Matsumoto, Naohiko Kobayashi, Ryo Suzuki, Yoshiko Tahira, Takahiro Ueno, Koichi Matsumoto. (2008) Effects of an ARB on Endothelial Progenitor Cell Function and Cardiovascular Oxidation in Hypertension. American Journal of Hypertension 21:1, 72-77
CrossRef415
Nahoko Ikeda, Takanori Yasu, Norifumi Kubo, Tomohiro Nakamura, Yoshitaka Sugawara, Shin-ichiro Ueda, San-e Ishikawa, Muneyasu Saito, Masanobu Kawakami, Shin-ichi Momomura. (2008) Daily Exercise and Bone Marrow-Derived CD34+/133+ Cells After Myocardial Infarction Treated by Bare Metal Stent Implantation. Circulation Journal 72:6, 897-901
CrossRef416
Kyeong Ho Yun, Ik-Sang Shin, Eun Mi Park, Sang Jae Rhee, Eun Mi Lee, Nam Jin Yoo, Nam-Ho Kim, Seok Kyu Oh, Jin-Won Jeong. (2008) Effect of Additional Statin Therapy on Endothelial Function and Prognosis in Patients With Vasospastic Angina. Korean Circulation Journal 38:12, 638
CrossRef417
Takashi Umemura, Yukihito Higashi. (2008) Endothelial Progenitor Cells: Therapeutic Target for Cardiovascular Diseases. Journal of Pharmacological Sciences 108:1, 1-6
CrossRef418
Cindy Grines, Leslie Cho. (2008) Atherothrombotic Disease and the Role of Antiplatelet Therapy in Women. Journal of Women's Health 17:1, 35-46
CrossRef419
Mónica de la Peña, Antonia Barceló, Ferran Barbe, Javier Piérola, Jaume Pons, Enric Rimbau, Olga Ayllón, Alvar G.N. Agustí. (2008) Endothelial Function and Circulating Endothelial Progenitor Cells in Patients with Sleep Apnea Syndrome. Respiration 76:1, 28-32
CrossRef420
Mahmoud M. Ramadan, Essam M. Mahfouz, Gamal F. Gomaa, Tarek A. El-Diasty, Louie Alldawi, Taruna Ikrar, Ding Limin, Makoto Kodama, Yoshifusa Aizawa. (2008) Evaluation of Coronary Calcium Score by Multidetector Computed Tomography in Relation to Endothelial Function and Inflammatory Markers in Asymptomatic Individuals. Circulation Journal 72:5, 778-785
CrossRef421
Thomas J. Povsic, Katherine L. Zavodni, Francine L. Kelly, Shoukang Zhu, Pascal J. Goldschmidt-Clermont, Chunming Dong, Eric D. Peterson. (2007) Circulating Progenitor Cells Can Be Reliably Identified on the Basis of Aldehyde Dehydrogenase Activity. Journal of the American College of Cardiology 50:23, 2243-2248
CrossRef422
Bertrand Lapergue, Askar Mohammad, Ashfaq Shuaib. (2007) Endothelial progenitor cells and cerebrovascular diseases. Progress in Neurobiology 83:6, 349-362
CrossRef423
Rakhi P. Naik, David Jin, Ellen Chuang, Ellen G. Gold, Eleni A. Tousimis, Anne L. Moore, Paul J. Christos, Tatiana Dalmas, Diana Donovan, Shahin Rafii, Linda T. Vahdat. (2007) Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Research and Treatment 107:1, 133-138
CrossRef424
Evangelos V. Badiavas, Dwayne Ford, Paul Liu, Nicola Kouttab, John Morgan, Amy Richards, Abby Maizel. (2007) Long-term bone marrow culture and its clinical potential in chronic wound healing. Wound Repair and Regeneration 15:6, 856-865
CrossRef425
Marlon P. Quinones, Hernan G. Martinez, Fabio Jimenez, Carlos A. Estrada, Molly Dudley, Opal Willmon, Hemant Kulkarni, Robert L. Reddick, Gabriel Fernandes, William A. Kuziel, Sunil K. Ahuja, Seema S. Ahuja. (2007) CC chemokine receptor 5 influences late-stage atherosclerosis. Atherosclerosis 195:1, e92-e103
CrossRef426
Nikos Werner, Sven Wassmann, Patrick Ahlers, Tobias Schiegl, Sonja Kosiol, Andreas Link, Katrin Walenta, Georg Nickenig. (2007) Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Research in Cardiology 102:6, 565-571
CrossRef427
Patrizio Sarto, Elena Balducci, Giovanna Balconi, Fabio Fiordaliso, Laura Merlo, Giancarlo Tuzzato, Giovanni L. Pappagallo, Nicoletta Frigato, Albino Zanocco, Concetta Forestieri, Giuseppe Azzarello, Antonio Mazzucco, Maria Teresa Valenti, Flora Alborino, Donatella Noventa, Orazio Vinante, Piero Pascotto, Saverio Sartore, Elisabetta Dejana, Roberto Latini. (2007) Effects of Exercise Training on Endothelial Progenitor Cells in Patients With Chronic Heart Failure. Journal of Cardiac Failure 13:9, 701-708
CrossRef428
Henricus Duckers, Thomas Soullié, Peter den Heijer, Benno Rensing, Robbert de Winter, Matthias Rau, Harald Mudra, Sigmund Silber, Edouard Benit, Stefan Verheye, William Wijns, Patrick Serruys. (2007) Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™. EuroIntervention 3:3, 350-358
CrossRef429
Pui Y. Lee, Yi Li, Hanno B. Richards, Fay S. Chan, Haoyang Zhuang, Sonali Narain, Edward J. Butfiloski, Eric S. Sobel, Westley H. Reeves, Mark S. Segal. (2007) Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis & Rheumatism 56:11, 3759-3769
CrossRef430
Tak Loon Khong, Helene Larsen, Yvonne Raatz, Ewa Paleolog. (2007) Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience. Angiogenesis 10:4, 243-258
CrossRef431
M. F. Denny, S. Thacker, H. Mehta, E. C. Somers, T. Dodick, F. J. Barrat, W. J. McCune, M. J. Kaplan. (2007) Interferon- promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 110:8, 2907-2915
CrossRef432
Matteo Pirro, Giuseppe Schillaci, Cinzia Menecali, Francesco Bagaglia, Rita Paltriccia, Gaetano Vaudo, Massimo R Mannarino, Elmo Mannarino. (2007) Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. Journal of Hypertension 25:10, 2093-2099
CrossRef433
Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi, Gerald B. Brock. (2007) Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications. European Urology 52:4, 990-1005
CrossRef434
Gian Paolo Fadini, Angelo Avogaro, Carlo Agostini. (2007) Critical Assessment of Putative Endothelial Progenitor Phenotypes. Experimental Hematology 35:10, 1479-1480
CrossRef435
T J Rabelink, D C Wijewickrama, E J de Koning. (2007) Peritubular endothelium: The Achilles heel of the kidney?. Kidney International 72:8, 926-930
CrossRef436
W. Sterry, B.E. Strober, A. Menter, . (2007) Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. British Journal of Dermatology 157:4, 649-655
CrossRef437
Eirik Sundlisæter, Aly Dicko, Per Øystein Sakariassen, Karl Sondenaa, Per Øyvind Enger, Rolf Bjerkvig. (2007) Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects. International Journal of Cancer 121:7, 1401-1409
CrossRef438
Marietta Charakida, John E Deanfield, Julian PJ Halcox. (2007) Childhood origins of arterial disease. Current Opinion in Pediatrics 19:5, 538-545
CrossRef439
Stephan Lindemann, Björn Krämer, Karin Daub, Konstantinos Stellos, Meinrad Gawaz. (2007) Molecular pathways used by platelets to initiate and accelerate atherogenesis. Current Opinion in Lipidology 18:5, 566-573
CrossRef440
G. P. Fadini, L. Pucci, R. Vanacore, I. Baesso, G. Penno, A. Balbarini, R. Stefano, R. Miccoli, S. Kreutzenberg, A. Coracina, A. Tiengo, C. Agostini, S. Prato, A. Avogaro. (2007) Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 50:10, 2156-2163
CrossRef441
N. A. Hanley. (2007) Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?. Diabetologia 50:10, 2033-2035
CrossRef442
Carlo Foresta, Daniela Zuccarello, Luca De Toni, Andrea Garolla, Nicola Caretta, Alberto Ferlin. (2007) Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clinical Endocrinology 0:0, 070907134102007-???
CrossRef443
(2007) Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Española de Cardiología 60:9, 968.e1-968.e94
CrossRef444
Gian Paolo Fadini, Carlo Agostini, Saverio Sartore, Angelo Avogaro. (2007) Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194:1, 46-54
CrossRef445
Fernando Vivanco, Sebastian Mas, Veronica M. Darde, Fernando De la Cuesta, Gloria Alvarez-Llamas, Maria G. Barderas. (2007) Vascular proteomics. PROTEOMICS – CLINICAL APPLICATIONS 1:9, 1102-1122
CrossRef446
Jonathan Golledge, Ann Van Campenhout, Shripad Pal, Catherine Rush. (2007) Bone marrow–derived cells and arterial disease. Journal of Vascular Surgery 46:3, 590-600
CrossRef447
Edward H. Lin, Manal Hassan, Yanan Li, Hua Zhao, Ajay Nooka, Elizabeth Sorenson, Keping Xie, Richard Champlin, Xifeng Wu, Donghui Li. (2007) Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 110:3, 534-542
CrossRef448
Yibo Wang, Yi Zheng, Weili Zhang, Hui Yu, Kejia Lou, Yu Zhang, Qin Qin, Bingrang Zhao, Ying Yang, Rutai Hui. (2007) Polymorphisms of KDR Gene Are Associated With Coronary Heart Disease. Journal of the American College of Cardiology 50:8, 760-767
CrossRef449
Paul R. Crisostomo, Troy A. Markel, Meijing Wang, Tim Lahm, Keith D. Lillemoe, Daniel R. Meldrum. (2007) In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 142:2, 215-221
CrossRef450
J. Bauersachs, T. Thum. (2007) Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches. European Journal of Clinical Investigation 37:8, 603-606
CrossRef451
Rishi Sharma, Ram Raghubir. (2007) Stem Cell Therapy: A Hope for Dying Hearts. Stem Cells and Development 16:4, 517-536
CrossRef452
Paul A. Brogan. (2007) What’s new in the aetiopathogenesis of vasculitis?. Pediatric Nephrology 22:8, 1083-1094
CrossRef453
Gitte S. Jensen, Aaron N. Hart, Lue A.M. Zaske, Christian Drapeau, Niraj Gupta, David J. Schaeffer, J. Alex Cruickshank. (2007) Mobilization of human CD34+CD133+ and CD34+CD133− stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae—related to modulation of CXCR4 expression by an L-selectin ligand?. Cardiovascular Revascularization Medicine 8:3, 189-202
CrossRef454
Jamie Case, Laura E. Mead, Waylan K. Bessler, Daniel Prater, Hilary A. White, M. Reza Saadatzadeh, Janak R. Bhavsar, Mervin C. Yoder, Laura S. Haneline, David A. Ingram. (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental Hematology 35:7, 1109-1118
CrossRef455
Jeremy Ben-Shoshan, Jacob George. (2007) Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: From experimental models to human trials. Pharmacology & Therapeutics 115:1, 25-36
CrossRef456
Eva Rohde, Christina Bartmann, Katharina Schallmoser, Andreas Reinisch, Gerhard Lanzer, Werner Linkesch, Christian Guelly, Dirk Strunk. (2007) Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro. Stem Cells 25:7, 1746-1752
CrossRef457
Neysan Rafat, Christine Hanusch, Paul T. Brinkkoetter, Jutta Schulte, Joachim Brade, Jan G. Zijlstra, Fokko J. van der Woude, Klaus van Ackern, Benito A. Yard, Grietje Ch. Beck. (2007) Increased circulating endothelial progenitor cells in septic patients: Correlation with survival. Critical Care Medicine 35:7, 1677-1684
CrossRef458
D N Prater, J Case, D A Ingram, M C Yoder. (2007) Working hypothesis to redefine endothelial progenitor cells. Leukemia 21:6, 1141-1149
CrossRef459
Christine K. Kissel, Ralf Lehmann, Birgit Assmus, Alexandra Aicher, Jörg Honold, Ulrich Fischer-Rasokat, Christopher Heeschen, Ioakim Spyridopoulos, Stefanie Dimmeler, Andreas M. Zeiher. (2007) Selective Functional Exhaustion of Hematopoietic Progenitor Cells in the Bone Marrow of Patients With Postinfarction Heart Failure. Journal of the American College of Cardiology 49:24, 2341-2349
CrossRef460
Mihail Hristov, Christian Fach, Carolin Becker, Nicole Heussen, Elisa A. Liehn, Rüdiger Blindt, Peter Hanrath, Christian Weber. (2007) Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192:2, 413-420
CrossRef461
E. Marc Jolicoeur, Christopher B. Granger, John L. Fakunding, Steven C. Mockrin, Steven M. Grant, Stephen G. Ellis, Richard D. Weisel, Margaret A. Goodell. (2007) Bringing cardiovascular cell-based therapy to clinical application: Perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. American Heart Journal 153:5, 732-742
CrossRef462
H. Rensing. (2007) Stammzellen und Sepsis. Der Anaesthesist 56:5, 421-422
CrossRef463
Carlo Foresta, Nicola Caretta, Andrea Lana, Luca De Toni, Andrea Biagioli, Cinzia Vinanzi, Alberto Ferlin. (2007) Relationship Between Vascular Damage Degrees and Endothelial Progenitor Cells in Patients with Erectile Dysfunction: Effect of Vardenafil Administration and PDE5 Expression in the Bone Marrow. European Urology 51:5, 1411-1419
CrossRef464
G.C. Beck, N. Rafat, B. Yard, C. Hanusch. (2007) Die Rolle endothelialer Vorläuferzellen in der Sepsis. Der Anaesthesist 56:5, 423-428
CrossRef465
George A. Mensah. (2007) Healthy endothelium: The scientific basis for cardiovascular health promotion and chronic disease prevention. Vascular Pharmacology 46:5, 310-314
CrossRef466
Allan S. Jaffe. (2007) Cardiovascular biomarkers: The state of the art in 2006. Clinica Chimica Acta 381:1, 9-13
CrossRef467
Guiti Z. Eghbali-Fatourechi, Ulrike I.L. Mödder, Natthinee Charatcharoenwitthaya, Arunik Sanyal, Anita H. Undale, Jackie A. Clowes, James E. Tarara, Sundeep Khosla. (2007) Characterization of circulating osteoblast lineage cells in humans. Bone 40:5, 1370-1377
CrossRef468
Endri Mauro, Gian Matteo Rigolin, Chiara Fraulini, Olga Sofritti, Maria Ciccone, Cristiano De Angeli, Gianluigi Castoldi, Antonio Cuneo. (2007) Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation. European Journal of Haematology 78:5, 374-380
CrossRef469
Christoph Gensch, Yvonne P. Clever, Christian Werner, Milad Hanhoun, Michael Böhm, Ulrich Laufs. (2007) The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 192:1, 67-74
CrossRef470
Daniel Bulut*, Nadine Albrecht*, Matthias Imöhl, Bülent Günesdogan, Nadine Bulut-Streich, Jan Börgel, Christoph Hanefeld, Michael Krieg, Andreas Mügge. (2007) Hormonal status modulates circulating endothelial progenitor cells. Clinical Research in Cardiology 96:5, 258-263
CrossRef471
Roland E Schmieder, Karl F Hilgers, Markus P Schlaich, Bernhard MW Schmidt. (2007) Renin-angiotensin system and cardiovascular risk. The Lancet 369:9568, 1208-1219
CrossRef472
Matthew T. Roe, Abdul R. Halabi, Rajendra H. Mehta, Anita Y. Chen, L. Kristin Newby, Robert A. Harrington, Sidney C. Smith, E. Magnus Ohman, W. Brian Gibler, Eric D. Peterson. (2007) Documented traditional cardiovascular risk factors and mortality in non–ST-segment elevation myocardial infarction. American Heart Journal 153:4, 507-514
CrossRef473
Eberhard RITZ, Ralf DIKOW, Marie-Luise GROSS. (2007) Dialysis, cardiovascular disease, and the future. Hemodialysis International 11:s1, S2-S11
CrossRef474
Chantal M Boulanger. (2007) New marker of atherosclerosis in hypercholesterolemia: an index relating endothelial injury to repair capacity. Future Lipidology 2:2, 153-155
CrossRef475
Ralf A. Benndorf, Ursula M. Gehling, Daniel Appel, Renke Maas, Edzard Schwedhelm, Kathleen Schlagner, Elisabeth Silberhorn, Dieter K. Hossfeld, Xavier Rogiers, Rainer Böger. (2007) Mobilization of Putative High-Proliferative-Potential Endothelial Colony-Forming Cells during Antihypertensive Treatment in Patients with Essential Hypertension. Stem Cells and Development 16:2, 329-338
CrossRef476
CHUNMING DONG, PASCAL J. GOLDSCHMIDT-CLERMONT. (2007) Endothelial Progenitor Cells: A Promising Therapeutic Alternative for Cardiovascular Disease. Journal of Interventional Cardiology 20:2, 93-99
CrossRef477
K-K Lau, Y-H Chan, K-H Yiu, S-W Li, S Tam, C-P Lau, Y-L Kwong, H-F Tse. (2007) Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. Journal of Human Hypertension
CrossRef478
Gilles Chironi, Laurence Walch, Marie-Gabrielle Pernollet, Jérôme Gariepy, Jaime Levenson, Francine Rendu, Alain Simon. (2007) Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 191:1, 115-120
CrossRef479
Andrzej Surdacki, Jens Martens-Lobenhoffer, Alicja Wloch, Ewa Marewicz, Tomasz Rakowski, Ewa Wieczorek-Surdacka, Jacek S. Dubiel, Juliusz Pryjma, Stefanie M. Bode-Böger. (2007) Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis & Rheumatism 56:3, 809-819
CrossRef480
Martin Friedlander. (2007) Fibrosis and diseases of the eye. Journal of Clinical Investigation 117:3, 576-586
CrossRef481
Javier Sanz, Pedro R Moreno, Valentin Fuster. (2007) Update on advances in atherothrombosis. Nature Clinical Practice Cardiovascular Medicine 4:2, 78-89
CrossRef482
Neil Roberts, Qingzhong Xiao, Graeme Weir, Qingbo Xu, Marjan Jahangiri. (2007) Endothelial Progenitor Cells are Mobilized After Cardiac Surgery. The Annals of Thoracic Surgery 83:2, 598-605
CrossRef483
Meifeng Xu, Ryota Uemura, Ying Dai, Yigang Wang, Zeeshan Pasha, Muhammad Ashraf. (2007) In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. Journal of Molecular and Cellular Cardiology 42:2, 441-448
CrossRef484
Valentin Fuster, Javier Sanz. (2007) Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research. Nature Clinical Practice Cardiovascular Medicine 4, S1-S8
CrossRef485
Ioakim Spyridopoulos, Stefanie Dimmeler. (2007) Can telomere length predict cardiovascular risk?. The Lancet 369:9556, 81-82
CrossRef486
Monique Hinchcliff, John Varga. (2007) Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapy. Expert Review of Clinical Immunology 3:1, 11-15
CrossRef487
Raquel Rodríguez-González, Olivia Hurtado, Tomás Sobrino, José Castillo. (2007) Neuroplasticity and Cellular Therapy in Cerebral Infarction. Cerebrovascular Diseases 24:1, 167-180
CrossRef488
Alessio Sturiale, Giuseppe Coppolino, Saverio Loddo, Manila Criseo, Susanna Campo, Eleonora Crascì, Davide Bolignano, Lorena Nostro, Diana Teti, Michele Buemi. (2007) Effects of Haemodialysis on Circulating Endothelial Progenitor Cell Count. Blood Purification 25:3, 242-251
CrossRef489
Greta L. Hoetzer, Owen J. MacEneaney, Heather M. Irmiger, Rebecca Keith, Gary P. Van Guilder, Brian L. Stauffer, Christopher A. DeSouza. (2007) Gender Differences in Circulating Endothelial Progenitor Cell Colony-Forming Capacity and Migratory Activity in Middle-Aged Adults. The American Journal of Cardiology 99:1, 46-48
CrossRef490
Sara D. Collins, Richard Baffour, Ron Waksman. (2007) Cell therapy in myocardial infarction. Cardiovascular Revascularization Medicine 8:1, 43-51
CrossRef491
Saif Anwaruddin, Arman T. Askari, Eric J. Topol. (2007) Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine. Journal of the American College of Cardiology 49:3, 279-289
CrossRef492
Tetsuya Tatsumi, Eishi Ashihara, Toshihide Yasui, Shinsaku Matsunaga, Atsumichi Kido, Yuji Sasada, Satoshi Nishikawa, Mitsuyoshi Hadase, Masahiro Koide, Reo Nakamura, Hidekazu Irie, Kazuki Ito, Akihiro Matsui, Hiroyuki Matsui, Maki Katamura, Shigehiro Kusuoka, Satoaki Matoba, Satoshi Okayama, Manabu Horii, Shiro Uemura, Chihiro Shimazaki, Hajime Tsuji, Yoshihiko Saito, Hiroaki Matsubara. (2007) Intracoronary Transplantation of Non-Expanded Peripheral Blood-Derived Mononuclear Cells Promotes Improvement of Cardiac Function in Patients With Acute Myocardial Infarction. Circulation Journal 71:8, 1199-1207
CrossRef493
Takayuki Asahara. 2007. Bone Marrow Cells and Vascular Growth. , 47-55.
CrossRef494
Valentin Fuster, Javier Sanz. (2007) Vascular inflammation. Journal of the American Society of Hypertension 1:1, 68-81
CrossRef495
G.L. Moneta. (2007) Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes. Yearbook of Vascular Surgery 2007, 11-12
CrossRef496
Pietro Delva, Maurizio Degan, Paola Vallerio, Enrico Arosio, Pietro Minuz, Gabriella Amen, Marzia Di Chio, Alessandro Lechi. (2007) Endothelial progenitor cells in patients with essential hypertension. Journal of Hypertension 25:1, 127-132
CrossRef497
Paul R. Crisostomo, Meijing Wang, George M. Wairiuko, Eric D. Morrell, Andrew M. Terrell, Preethi Seshadri, Un Hui Nam, Daniel R. Meldrum. (2006) HIGH PASSAGE NUMBER OF STEM CELLS ADVERSELY AFFECTS STEM CELL ACTIVATION AND MYOCARDIAL PROTECTION. Shock 26:6, 575-580
CrossRef498
Paul R. Crisostomo, Meijing Wang, Christine M. Herring, Eric D. Morrell, Preethi Seshadri, Kirstan K. Meldrum, Daniel R. Meldrum. (2006) SEX DIMORPHISMS IN ACTIVATED MESENCHYMAL STEM CELL FUNCTION. Shock 26:6, 571-574
CrossRef499
K. Herbrig, K. Gebler, U. Oelschlaegel, F. Pistrosch, S. Foerster, A. Wagner, P. Gross, J. Passauer. (2006) Kidney Transplantation Substantially Improves Endothelial Progenitor Cell Dysfunction in Patients with End-Stage Renal Disease. American Journal of Transplantation 6:12, 2922-2928
CrossRef500
Angelo Avogaro, Gian Paolo Fadini. (2006) The Janus Face of Nicotinic Angiogenesis
CrossRef501
Dick H. J. Thijssen, Joost B. Vos, Caroline Verseyden, Anton Jan van Zonneveld, Paul Smits, Fred C. G. J. Sweep, Maria T. E. Hopman, Hetty C. de Boer. (2006) Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 5:6, 495-503
CrossRef502
Erik Lipšic, Regien G. Schoemaker, Peter van der Meer, Adriaan A. Voors, Dirk J. van Veldhuisen, Wiek H. van Gilst. (2006) Protective Effects of Erythropoietin in Cardiac Ischemia. Journal of the American College of Cardiology 48:11, 2161-2167
CrossRef503
Ioannis Andreou, Dimitris Tousoulis, Costas Tentolouris, Charalambos Antoniades, Christodoulos Stefanadis. (2006) Potential role of endothelial progenitor cells in the pathophysiology of heart failure: Clinical implications and perspectives. Atherosclerosis 189:2, 247-254
CrossRef504
Karen Mendelson, Frederick J. Schoen. (2006) Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges. Annals of Biomedical Engineering 34:12, 1799-1819
CrossRef505
G. P. Fadini, S. Sartore, M. Schiavon, M. Albiero, I. Baesso, A. Cabrelle, C. Agostini, A. Avogaro. (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats. Diabetologia 49:12, 3075-3084
CrossRef506
Paul E. Szmitko, Michael J.B. Kutryk, Duncan J. Stewart, Martin H. Strauss, Subodh Verma. (2006) Endothelial progenitor cell-coated stents under scrutiny. Canadian Journal of Cardiology 22:13, 1117-1119
CrossRef507
Uta Erdbruegger, Marion Haubitz, Alexander Woywodt. (2006) Circulating endothelial cells: A novel marker of endothelial damage. Clinica Chimica Acta 373:1-2, 17-26
CrossRef508
Francesco Bertolini, Yuval Shaked, Patrizia Mancuso, Robert S. Kerbel. (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nature Reviews Cancer 6:11, 835-845
CrossRef509
Subhash Banerjee, Emmanouil Brilakis, Shuqi Zhang, Michele Roesle, Jason Lindsey, Binu Philips, Christopher G. Blewett, Lance S. Terada. (2006) Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 189:1, 70-75
CrossRef510
Christopher J. Boos, Gregory Y.H. Lip, Andrew D. Blann. (2006) Circulating Endothelial Cells in Cardiovascular Disease. Journal of the American College of Cardiology 48:8, 1538-1547
CrossRef511
Klara Brixius, Fabienne Funcke, Christine Graf, Wilhelm Bloch. (2006) Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases. European Journal of Cardiovascular Prevention & Rehabilitation 13:5, 705-710
CrossRef512
Jonathan Leor, Michael Marber. (2006) Endothelial Progenitors. Journal of the American College of Cardiology 48:8, 1588-1590
CrossRef513
Hasan Güven, Rebecca M. Shepherd, Richard G. Bach, Benjamin J. Capoccia, Daniel C. Link. (2006) The Number of Endothelial Progenitor Cell Colonies in the Blood Is Increased in Patients With Angiographically Significant Coronary Artery Disease. Journal of the American College of Cardiology 48:8, 1579-1587
CrossRef514
Lunde, Ketil, Solheim, Svein, Aakhus, Svend, Arnesen, Harald, Abdelnoor, Michael, Egeland, Torstein, Endresen, Knut, Ilebekk, Arnfinn, Mangschau, Arild, Fjeld, Jan G., Smith, Hans Jørgen, Taraldsrud, Eli, Grøgaard, Haakon Kiil, Bjørnerheim, Reidar, Brekke, Magne, Müller, Carl, Hopp, Einar, Ragnarsson, Asgrimur, Brinchmann, Jan E., Forfang, Kolbjørn, . (2006) Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction. New England Journal of Medicine 355:12, 1199-1209
Full Text515
Andrew D. Blann, Adolf Pretorius. (2006) Circulating endothelial cells and endothelial progenitor cells: Two sides of the same coin, or two different coins?. Atherosclerosis 188:1, 12-18
CrossRef516
Harald C Ott, Doris A Taylor. (2006) From cardiac repair to cardiac regeneration – ready to translate?. Expert Opinion on Biological Therapy 6:9, 867-878
CrossRef517
Matthew A. Roberts, David L. Hare, Sujiva Ratnaike, Francesco L. Ierino. (2006) Cardiovascular Biomarkers in CKD: Pathophysiology and Implications for Clinical Management of Cardiac Disease. American Journal of Kidney Diseases 48:3, 341-360
CrossRef518
C Foresta, A Ferlin, L De Toni, A Lana, C Vinanzi, A Galan, N Caretta. (2006) Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction. International Journal of Impotence Research 18:5, 484-488
CrossRef519
Gilad E. Amiel, Makoto Komura, Oz Shapira, James J. Yoo, Saami Yazdani, Joel Berry, Sunjay Kaushal, Joyce Bischoff, Anthony Atala, Shay Soker. (2006) Engineering of Blood Vessels from Acellular Collagen Matrices Coated with Human Endothelial Cells. Tissue Engineering 0:0, 060913044658035
CrossRef520
Nicoletta Del Papa, Nadia Quirici, Davide Soligo, Cinzia Scavullo, Michela Cortiana, Chiara Borsotti, Wanda Maglione, Denise P. Comina, Claudio Vitali, Paolo Fraticelli, Armando Gabrielli, Agostino Cortelezzi, Giorgio Lambertenghi-Deliliers. (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis & Rheumatism 54:8, 2605-2615
CrossRef521
Richard C. Becker, Felicita Andreotti. (2006) Preoteomics, metabolomics and progenitor cells in acute coronary syndromes. Journal of Thrombosis and Thrombolysis 22:1, 85-88
CrossRef522
Gilad E. Amiel, Makoto Komura, Oz Shapira, James J. Yoo, Saami Yazdani, Joel Berry, Sunjay Kaushal, Joyce Bischoff, Anthony Atala, Shay Soker. (2006) Engineering of Blood Vessels from Acellular Collagen Matrices Coated with Human Endothelial Cells. Tissue Engineering 12:8, 2355-2365
CrossRef523
Christoph Kalka, Stefano Di Santo. (2006) Endothelial progenitor cells: from bench to bedside. Future Cardiology 2:4, 455-466
CrossRef524
Dirk Skowasch, Martin Steinmetz, Georg Nickenig, Gerhard Bauriedel. (2006) Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. Expert Review of Medical Devices 3:4, 453-462
CrossRef525
Robert M. Clancy. (2006) Preventing and repairing vascular damage in scleroderma: Should we focus beyond vasodilatation to recruitment of endothelial precursor cells?. Arthritis & Rheumatism 54:6, 1730-1732
CrossRef526
Joël Constans, Claude Conri. (2006) Circulating markers of endothelial function in cardiovascular disease. Clinica Chimica Acta 368:1-2, 33-47
CrossRef527
L. BONELLO, A. BASIRE, F. SABATIER, F. PAGANELLI, F. DIGNAT-GEORGE. (2006) Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease1. Journal of Thrombosis and Haemostasis 4:5, 979-981
CrossRef528
Emerson E. Sharpe, Amylynn A. Teleron, Bin Li, James Price, Mark S. Sands, Kathy Alford, Pampee P. Young. (2006) The Origin and in Vivo Significance of Murine and Human Culture-Expanded Endothelial Progenitor Cells. The American Journal of Pathology 168:5, 1710-1721
CrossRef529
T. Q. Nguyen, H. Chon, F. A. Nieuwenhoven, B. Braam, M. C. Verhaar, R. Goldschmeding. (2006) Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?. Diabetologia 49:5, 1039-1048
CrossRef530
Thomas J Povsic, Eric D Peterson. (2006) Stem cells for the ischaemic heart. Expert Opinion on Biological Therapy 6:5, 427-442
CrossRef531
Kivilcim Yavuz, Serdar Geyik, Dusan Pavcnik, Barry T. Uchida, Christopher L. Corless, David E. Hartley, Ahmet Goktay, Luiz Otavio Correa, Hans Timmermans, Jason P. Hodde. (2006) Comparison of the Endothelialization of Small Intestinal Submucosa, Dacron, and Expanded Polytetrafluoroethylene Suspended in the Thoracoabdominal Aorta in Sheep. Journal of Vascular and Interventional Radiology 17:5, 873-882
CrossRef532
Irmgard Tegeder, Gerd Geisslinger. (2006) Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?. Naunyn-Schmiedeberg's Archives of Pharmacology 373:1, 1-17
CrossRef533
E D de Muinck, C Thompson, M Simons. (2006) Progress and prospects: Cell based regenerative therapy for cardiovascular disease. Gene Therapy 13:8, 659-671
CrossRef534
PASQUALE GALLO, CESARE PESCHLE, GIANLUIGI CONDORELLI. (2006) Sources of Cardiomyocytes for Stem Cell Therapy: An Update. Pediatric Research 59:Supplement 1, 79R-83R
CrossRef535
N. Werner, G. Nickenig. (2006) Clinical and therapeutical implications of EPC biology in atherosclerosis. Journal of Cellular and Molecular Medicine 10:2, 318-332
CrossRef536
Erik Lipšic, Peter Meer, Adriaan A. Voors, B. Daan Westenbrink, Ad F. M. Heuvel, Hetty C. Boer, Anton J. Zonneveld, Regien G. Schoemaker, Wiek H. Gilst, Felix Zijlstra, Dirk J. Veldhuisen. (2006) A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study. Cardiovascular Drugs and Therapy 20:2, 135-141
CrossRef537
Richard C. Becker. (2006) Preoteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes. Journal of Thrombosis and Thrombolysis 21:2, 203-206
CrossRef538
Anton-Jan van Zonneveld, Ton J Rabelink. (2006) Endothelial progenitor cells: biology and therapeutic potential in hypertension. Current Opinion in Nephrology and Hypertension 15:2, 167-172
CrossRef539
Satoshi Shintani, Kengo Kusano, Masaaki Ii, Atsushi Iwakura, Lindsay Heyd, Cynthia Curry, Andrea Wecker, Mary Gavin, Hong Ma, Marianne Kearney, Marcy Silver, Tina Thorne, Toyoaki Murohara, Douglas W Losordo. (2006) Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nature Clinical Practice Cardiovascular Medicine 3, S123-S128
CrossRef540
Ernesto Rodríguez-Ayala, Qiang Yao, Carolina Holmén, Bengt Lindholm, Suchitra Sumitran-Holgersson, Peter Stenvinkel. (2006) Imbalance between Detached Circulating Endothelial Cells and Endothelial Progenitor Cells in Chronic Kidney Disease. Blood Purification 24:2, 196-202
CrossRef541
(2005) Circulating Endothelial Progenitor Cells. New England Journal of Medicine 353:24, 2613-2616
Full Text542
S. M. Watt, A. Fox. (2005) Blood vessel stem cells and wound healing. British Journal of Surgery 92:12, 1461-1463
CrossRef543
H. C. Ott, J. McCue, D. A. Taylor. (2005) Cell–based cardiovascular repair. Basic Research in Cardiology 100:6, 504-517
CrossRef544
Rosenzweig, Anthony, . (2005) Circulating Endothelial Progenitors — Cells as Biomarkers. New England Journal of Medicine 353:10, 1055-1057
Full Text
- Letters
